Oncology based company, Curis, Inc. (CRIS), announced earlier today the appointment of Dr. Mani Mohindru as Vice President of Corporate Strategy and Investor Relations. Dr. Mohindru, recruited for her expertise and experience supporting development and corporate strategy will direct product strategy, corporate development, investor relations and corporate communications. Curis, Inc. currently seeks to both develop and commercialize next generation targeted drug candidates for cancer treatment purposes.
“Dr. Mohindru brings to Curis a strong and unique understanding of cancer drug markets and development strategies due to her wealth of experience in the analysis of the biotechnology sector,” stated Mike Gray, Curis Chief Business and Financial Officer. “Mani’s diverse set of industry knowledge, professional networks, and experience will be an important addition to our team as we seek to advance our pipeline of novel oncology drug candidates for patients and work to create long-term shareholder value.”
Previously Dr. Mohindru spent several years as a Wall Street equity research analyst. Covering the biotechnology sector, she has held prominent positions including analyst roles at ThinkEquity LLC, Credit Suisse Securities and UBS Securities. Prior to that Dr. Mohindru sat as a healthcare industry consultant for Axon Healthcare Partners and SAI Healthcare, acquired by IMS Health, and additionally as a Managing Director in healthcare investment banking for Capstone Investments. Dr. Mohindru currently holds a Ph.D. in Neurosciences from Northwestern University. She also holds a B.Sc. in Human Biology and a M.S. in Biotechnology from the All India Institute of Medical Sciences, New Delhi, India.
“I am excited to join the Curis team as the company continues to advance its proprietary cancer drug candidates CUDC-907 and CUDC-427 in clinical trials, and to work with our partners Genentech and Debiopharm on Erivedge(R) and Debio 0932,” commented Dr. Mohindru. “Given these achievements, I believe Curis is well-positioned to leverage its expertise in developing cancer therapeutics and become a leading innovator of targeted oncology drug candidates.”
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Friday, May 31, 2013
FAB Universal Announces Kiosk Advertising Agreement with Shanghai Qiujia Culture Media
FAB Universal (FU), a distributor of digital entertainment across the globe, announced today that it has reached an advertising agreement with Shanghai Qiujia Culture Media to provide advertising on the top screen of the FAB Intelligent Media Kiosk Network. Annual revenue over the course of this five year, non-exclusive agreement is anticipated to equal over $1.6 million.
Shanghai Qiujia Media is an outdoor media company engaging in advertisement design, production, and distribution. Quijia Media operates interactive media advertising, while simultaneously serving as an Information Network system equipment supplier. In 2008, Qiujia Media worked alongside Shanghai Transport Investment Corporation in the development of a Public Information Network System. This new system would own the electronic information transport publishing rights for publishing advertisements and other data to railways, buses, and subways.
FAB’s business model is based on the sale of licenses, ongoing media content downloads, media membership cards, and kiosk-based advertising from its Intelligent Media Kiosk Business. FAB gives consumers the ability to purchase and download copyrighted music, video games, and movies directly to their mobile devices, such as cell phones and tablets. In addition, FAB Media Kiosks can run video ads on the built in LCD screens and accept payments for utility bills, metro cards, credit card bills, and other services.
For further information, please visit www.fabuniversal.com
FAB Universal Announces Kiosk Advertising Agreement with Shanghai Qiujia Culture Media
FAB Universal (FU), a distributor of digital entertainment across the globe, announced today that it has reached an advertising agreement with Shanghai Qiujia Culture Media to provide advertising on the top screen of the FAB Intelligent Media Kiosk Network. Annual revenue over the course of this five year, non-exclusive agreement is anticipated to equal over $1.6 million.
Shanghai Qiujia Media is an outdoor media company engaging in advertisement design, production, and distribution. Quijia Media operates interactive media advertising, while simultaneously serving as an Information Network system equipment supplier. In 2008, Qiujia Media worked alongside Shanghai Transport Investment Corporation in the development of a Public Information Network System. This new system would own the electronic information transport publishing rights for publishing advertisements and other data to railways, buses, and subways.
FAB’s business model is based on the sale of licenses, ongoing media content downloads, media membership cards, and kiosk-based advertising from its Intelligent Media Kiosk Business. FAB gives consumers the ability to purchase and download copyrighted music, video games, and movies directly to their mobile devices, such as cell phones and tablets. In addition, FAB Media Kiosks can run video ads on the built in LCD screens and accept payments for utility bills, metro cards, credit card bills, and other services.
For further information, please visit www.fabuniversal.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Shanghai Qiujia Media is an outdoor media company engaging in advertisement design, production, and distribution. Quijia Media operates interactive media advertising, while simultaneously serving as an Information Network system equipment supplier. In 2008, Qiujia Media worked alongside Shanghai Transport Investment Corporation in the development of a Public Information Network System. This new system would own the electronic information transport publishing rights for publishing advertisements and other data to railways, buses, and subways.
FAB’s business model is based on the sale of licenses, ongoing media content downloads, media membership cards, and kiosk-based advertising from its Intelligent Media Kiosk Business. FAB gives consumers the ability to purchase and download copyrighted music, video games, and movies directly to their mobile devices, such as cell phones and tablets. In addition, FAB Media Kiosks can run video ads on the built in LCD screens and accept payments for utility bills, metro cards, credit card bills, and other services.
For further information, please visit www.fabuniversal.com
FAB Universal Announces Kiosk Advertising Agreement with Shanghai Qiujia Culture Media
FAB Universal (FU), a distributor of digital entertainment across the globe, announced today that it has reached an advertising agreement with Shanghai Qiujia Culture Media to provide advertising on the top screen of the FAB Intelligent Media Kiosk Network. Annual revenue over the course of this five year, non-exclusive agreement is anticipated to equal over $1.6 million.
Shanghai Qiujia Media is an outdoor media company engaging in advertisement design, production, and distribution. Quijia Media operates interactive media advertising, while simultaneously serving as an Information Network system equipment supplier. In 2008, Qiujia Media worked alongside Shanghai Transport Investment Corporation in the development of a Public Information Network System. This new system would own the electronic information transport publishing rights for publishing advertisements and other data to railways, buses, and subways.
FAB’s business model is based on the sale of licenses, ongoing media content downloads, media membership cards, and kiosk-based advertising from its Intelligent Media Kiosk Business. FAB gives consumers the ability to purchase and download copyrighted music, video games, and movies directly to their mobile devices, such as cell phones and tablets. In addition, FAB Media Kiosks can run video ads on the built in LCD screens and accept payments for utility bills, metro cards, credit card bills, and other services.
For further information, please visit www.fabuniversal.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Lexicon Pharmaceuticals, Inc. (LXRX) Video Chart for Friday, May 31, 2013
LXRX made a solid 7 percent move on Thursday on increased volume to gap through a resistance point. More resistance is at $2.40, but the indicators are showing a strong trend and momentum which increases the odds of the resistance being broken and the chart continuing to build on its upward path.
To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
VistaGen Therapeutics, Inc. (VSTA) and the Small Molecule
In the challenging world of drug development and production, one of the first factors to be considered is whether a drug will be a small molecule or big molecule drug. Big molecule drugs are often called simply biologics, although other terms are sometimes used for certain types of big molecule drugs. They are therapeutic drugs produced using biological processes, engineered from a living organism, and can be made up of complex proteins, nucleic acids, or even living cells. They’re useful in treating certain types of problems, but also have significant limitations, such as the fact that they can almost never be taken orally. In addition, they can be difficult to manufacture, which in turn can make them very expensive.
Small molecule drugs, on the other hand, can be chemically synthesized and are far easier to produce in volume. Small molecule drugs are the most common type of drug produced, and represent the heart of today’s pharmaceutical industry. Nevertheless, it can still be extremely expensive to research, develop, test, and market a brand new small-molecule drug. And, because small molecule drugs are such big business, anything that can help improve this process has enormous potential.
VistaGen Therapeutics is a California-based biotech company focused primarily on the use of its proprietary stem cell technology to discover, rescue, and develop novel drug candidates for a wide range of diseases. This process generates new chemical variants of once-promising small molecule drug candidates that pharmaceutical companies have put on hold during preclinical or early clinical trials due to heart or liver toxicity, which is to say that the drugs were effective but had some toxic side effects. Using pluripotent stem cells as the base for their Human Clinical Trials in a Test Tube bioassay platform, VistaGen is able to more efficiently and cost effectively test for toxicity, allowing such drugs to be economically modified and rescued from the shelf.
For additional information, visit the company’s website at www.VistaGen.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Small molecule drugs, on the other hand, can be chemically synthesized and are far easier to produce in volume. Small molecule drugs are the most common type of drug produced, and represent the heart of today’s pharmaceutical industry. Nevertheless, it can still be extremely expensive to research, develop, test, and market a brand new small-molecule drug. And, because small molecule drugs are such big business, anything that can help improve this process has enormous potential.
VistaGen Therapeutics is a California-based biotech company focused primarily on the use of its proprietary stem cell technology to discover, rescue, and develop novel drug candidates for a wide range of diseases. This process generates new chemical variants of once-promising small molecule drug candidates that pharmaceutical companies have put on hold during preclinical or early clinical trials due to heart or liver toxicity, which is to say that the drugs were effective but had some toxic side effects. Using pluripotent stem cells as the base for their Human Clinical Trials in a Test Tube bioassay platform, VistaGen is able to more efficiently and cost effectively test for toxicity, allowing such drugs to be economically modified and rescued from the shelf.
For additional information, visit the company’s website at www.VistaGen.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Rafarma Pharmaceuticals, Inc. (RAFA) and Big Pharma
It’s almost impossible to talk about the economy and living standards without eventually getting caught up in a sometimes polarizing discussion about the high cost of healthcare. Spending for healthcare, as a percentage of GDP, has grown almost everywhere in the world, including the United States. Public resentment remains understandably high in this country as the pharmaceutical industry becomes bigger and more influential, generating a sense that the largest players are starting to depend more on marketing and lobbying than on visionary research.
If Americans are reeling under the onslaught of high drug prices, it’s a feeling shared around the world, especially in countries still struggling to build their per capita GDP to higher industrialized levels. The largest pharmaceutical companies are based in the U.S. and Europe, and countries outside that sphere have even less influence and control over prices and procedures. But basic medicines are critical to the health of every country, which has driven the Russian government to ramp up a major campaign for pharmaceutical independence.
Representative of this ongoing move is Rafarma Pharmaceuticals, a newly-built and fast-growing company in Russia that is being actively encouraged by the Russian government as a developing source for critical pharmaceuticals, independent of Big Pharma. The company has already built the most technologically advanced pharmaceutical plant in Russia, and aims to manufacture a range of generic and alternative pharmaceutical products available for sale at “mass market” prices, reduced in some cases by 30%-40% under typical import prices.
With a target market of over 100 million people, and with strong government support to grease the wheels, the company’s prospects are impressive. They are already being considered for the role of principal supplier to the Russian Public Health system and the Russian Army.
For more information, visit www.rafarma.us
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
If Americans are reeling under the onslaught of high drug prices, it’s a feeling shared around the world, especially in countries still struggling to build their per capita GDP to higher industrialized levels. The largest pharmaceutical companies are based in the U.S. and Europe, and countries outside that sphere have even less influence and control over prices and procedures. But basic medicines are critical to the health of every country, which has driven the Russian government to ramp up a major campaign for pharmaceutical independence.
Representative of this ongoing move is Rafarma Pharmaceuticals, a newly-built and fast-growing company in Russia that is being actively encouraged by the Russian government as a developing source for critical pharmaceuticals, independent of Big Pharma. The company has already built the most technologically advanced pharmaceutical plant in Russia, and aims to manufacture a range of generic and alternative pharmaceutical products available for sale at “mass market” prices, reduced in some cases by 30%-40% under typical import prices.
With a target market of over 100 million people, and with strong government support to grease the wheels, the company’s prospects are impressive. They are already being considered for the role of principal supplier to the Russian Public Health system and the Russian Army.
For more information, visit www.rafarma.us
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Marathon Patent Group, Inc.’s (MARA) Bismarck Acquires Batch of Patents, Applications from Siemens
Bismarck IP, wholly owned subsidiary of intellectual property services and patent licensing company Marathon Patent Group, as part of a previous agreement has acquired three U.S. and 10 international patents and patent applications from Siemens. The acquired patents support connections between communication terminal equipment specific performance features and which relate to the setup of the communication connection, or adding functions to an existing call, such as call waiting or call forwarding.
The acquired portfolio includes:
• U.S. Patents 5,734,832, “Method for Evaluating Performance-Feature-Related Messages in a Program-Controlled Communication Equipment”
• 5,883,896, “Arrangement for Coupling Optional Auxiliary Devices to Terminal Equipment of Private Branch Exchanges”
• 6,674,848, “Method for Displaying Performance Feature Names at a Communication Terminal Equipment”
Marathon has recruited the assistance of strategic partner IPNavigation Group to help identify and monetize the acquired patents.
“The Siemens portfolio provides Marathon with new assets to add to its recent series of strategic patent acquisitions,” Doug Croxall, Marathon Patent Group’s CEO, stated in the press release. “This is a strategic portfolio for Marathon’s subsidiary, Bismarck IP, and we look forward to working with IP Nav on exploring the different monetization opportunities with these IP assets.”
For more information visit www.marathonpg.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
The acquired portfolio includes:
• U.S. Patents 5,734,832, “Method for Evaluating Performance-Feature-Related Messages in a Program-Controlled Communication Equipment”
• 5,883,896, “Arrangement for Coupling Optional Auxiliary Devices to Terminal Equipment of Private Branch Exchanges”
• 6,674,848, “Method for Displaying Performance Feature Names at a Communication Terminal Equipment”
Marathon has recruited the assistance of strategic partner IPNavigation Group to help identify and monetize the acquired patents.
“The Siemens portfolio provides Marathon with new assets to add to its recent series of strategic patent acquisitions,” Doug Croxall, Marathon Patent Group’s CEO, stated in the press release. “This is a strategic portfolio for Marathon’s subsidiary, Bismarck IP, and we look forward to working with IP Nav on exploring the different monetization opportunities with these IP assets.”
For more information visit www.marathonpg.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Capstone Turbine Corp. (CPST) Receives Order from Nation’s Largest Natural Gas Distribution Utility to Provide Hybrid UPS for Green Data Center
Capstone Turbine, the world’s leading clean technology manufacturer of microturbine energy systems, received an order from California Gas Company (SoCalGas), the nation’s largest natural gas utility, for three patented C65 Hybrid Uninterruptible Power Source (Hybrid UPS) to be installed at the company’s data center.
The world’s first UPS system that integrates low-emission microturbines directly with a dual-conversion UPS, Capstone’s Hybrid UPS provides low-emission and highly reliable power for mission-critical loads.
Regatta Solutions, Inc., Capstone’s Southern California distributor, secured the order that features several Hybrid UPS microturbines deployed for critical load application. The Hybrid UPS provides an alternative to traditional UPS solutions and can easily integrate with an absorption chiller to create a combined cooling, heating, and power (CCHP) system which provides IT-grade power (eight 9′s reliability), facility heat, and chilled water for space cooling.
SoCalGas’s data center, located in Monterey Park, California, will be outfitted with Capstone Hybrid UPS microturbine units and an advanced double-effect Thermax exhaust-fired absorption chiller. The turbines will generate clean-and-green power onsite that will support critical loads. The microturbines will utilize clean waste-heat energy to drive the absorption chiller to meet the data center’s cooling needs in the summer and support heating needs in the winter.
SoCalGas operates in more than 500 Southern California communities, providing safe and reliable energy to 20.9 million consumers. The company’s services a territory that encompasses approximately 20,000 square miles.
“When used in a UPS application, the Capstone Hybrid UPS units emit ultra-low greenhouse-gas emissions and do not produce hazardous materials common with traditional battery-based UPS systems, which makes them the optimal clean-and-green power system for SoCalGas,” commented Darren Jamison, Capstone’s President and Chief Executive Officer.
“Since its market introduction in 2008, Capstone’s Hybrid UPS has proven to be a key component of green, energy-efficient data centers,” stated Jim Crouse, Capstone’s Executive Vice President, Sales and Marketing. “In addition to its reliability and economic benefits, Capstone’s Hybrid UPS can be used in a CCHP application, making it extremely efficient.”
For more information on Capstone Turbine Corporation, please visit www.capstoneturbine.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
The world’s first UPS system that integrates low-emission microturbines directly with a dual-conversion UPS, Capstone’s Hybrid UPS provides low-emission and highly reliable power for mission-critical loads.
Regatta Solutions, Inc., Capstone’s Southern California distributor, secured the order that features several Hybrid UPS microturbines deployed for critical load application. The Hybrid UPS provides an alternative to traditional UPS solutions and can easily integrate with an absorption chiller to create a combined cooling, heating, and power (CCHP) system which provides IT-grade power (eight 9′s reliability), facility heat, and chilled water for space cooling.
SoCalGas’s data center, located in Monterey Park, California, will be outfitted with Capstone Hybrid UPS microturbine units and an advanced double-effect Thermax exhaust-fired absorption chiller. The turbines will generate clean-and-green power onsite that will support critical loads. The microturbines will utilize clean waste-heat energy to drive the absorption chiller to meet the data center’s cooling needs in the summer and support heating needs in the winter.
SoCalGas operates in more than 500 Southern California communities, providing safe and reliable energy to 20.9 million consumers. The company’s services a territory that encompasses approximately 20,000 square miles.
“When used in a UPS application, the Capstone Hybrid UPS units emit ultra-low greenhouse-gas emissions and do not produce hazardous materials common with traditional battery-based UPS systems, which makes them the optimal clean-and-green power system for SoCalGas,” commented Darren Jamison, Capstone’s President and Chief Executive Officer.
“Since its market introduction in 2008, Capstone’s Hybrid UPS has proven to be a key component of green, energy-efficient data centers,” stated Jim Crouse, Capstone’s Executive Vice President, Sales and Marketing. “In addition to its reliability and economic benefits, Capstone’s Hybrid UPS can be used in a CCHP application, making it extremely efficient.”
For more information on Capstone Turbine Corporation, please visit www.capstoneturbine.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Thursday, May 30, 2013
StreamTrack, Inc. (STTK) Offers Superior Technologies for Reaching Target Markets
StreamTrack’s stated mission is to provide broadcasters and publishers with the tools necessary to maximize their revenue while decreasing or even eliminating their expenses. They do this by giving advertisers a simpler and more cost-effective means of reaching their target audience, while offering consumers free entertaining content.
For broadcasters, StreamTrack’s RadioLoyalty is one of the first service providers to make Internet Radio broadcasting profitable for radio stations. The system’s patent pending video ad insertion technology allows premium paying video advertisers to be viewed during commercial breaks for online listeners. This provides a decided advantage over anyone else in the industry and, combined with RadioLoyalty’s business model, has allowed stations to eliminate expenses and earn revenue that was never previously possible. As a result, instead of a bill, StreamTrack sends a check for the online advertising revenue the broadcaster has generated.
StreamTrack lets advertisers impact tens of millions of people each month with engaging display and video advertising, providing a cost-effective means to reach their audience at scale. Video in particular is one of the fasted growing online advertising formats, with an expected growth of over 40% this year. RadioLoyalty offers a competitive edge with patent pending in-stream video technology, transforming the 6B monthly audio impressions into video impressions. This allows the company to place video campaigns in front of an audience exclusive to RadioLoyalty. For publishers, StreamTrack has extensive knowledge of the digital and mobile industry.
StreamTrack has established its credentials in the business, and knows traffic, whether it’s sourced via display, mobile, lead gen, search, or social. For clients, the company offers multiple pay models: Cost-per-thousand (CPM), Cost-per-view (CPV), Cost-per-Lead (CPL), SEO, Social media, and Virtual Currency.
For more information, visit www.StreamTrack.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
ISCO
For broadcasters, StreamTrack’s RadioLoyalty is one of the first service providers to make Internet Radio broadcasting profitable for radio stations. The system’s patent pending video ad insertion technology allows premium paying video advertisers to be viewed during commercial breaks for online listeners. This provides a decided advantage over anyone else in the industry and, combined with RadioLoyalty’s business model, has allowed stations to eliminate expenses and earn revenue that was never previously possible. As a result, instead of a bill, StreamTrack sends a check for the online advertising revenue the broadcaster has generated.
StreamTrack lets advertisers impact tens of millions of people each month with engaging display and video advertising, providing a cost-effective means to reach their audience at scale. Video in particular is one of the fasted growing online advertising formats, with an expected growth of over 40% this year. RadioLoyalty offers a competitive edge with patent pending in-stream video technology, transforming the 6B monthly audio impressions into video impressions. This allows the company to place video campaigns in front of an audience exclusive to RadioLoyalty. For publishers, StreamTrack has extensive knowledge of the digital and mobile industry.
StreamTrack has established its credentials in the business, and knows traffic, whether it’s sourced via display, mobile, lead gen, search, or social. For clients, the company offers multiple pay models: Cost-per-thousand (CPM), Cost-per-view (CPV), Cost-per-Lead (CPL), SEO, Social media, and Virtual Currency.
For more information, visit www.StreamTrack.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
ISCO
Polar Petroleum Corp. (POLR) Analysis of Well Data On and Near Alaska Projects to Lead to Improved Production, Resource Mapping
Polar Petroleum, the domestic oil and gas developer based up in Anchorage – which has three key projects in the same region as two of America’s largest oil fields, announced today that they will use local geoscience/engineering firm, Waters Petroleum, LLC (WPA) to obtain well data and petrophysical evaluations for four wells that will yield viable pay interval and prospective zone analytics for POLR’s onshore Hemi Springs and Franklin Bluffs projects.
This is a huge boon for POLR to strike such a deal with WPA, who is well-known throughout Alaska (their base of operations) and Texas for their comprehensive oil and gas services portfolio, spanning the operational spectrum with personnel that also have vast experience on the E&P and research end of things. These guys handle everything from development and wellsite geology, to geological and geophysical interpretation, as well as geosteering and log editing with full quality control. WPA offers some of the best minds in the business and is making a name for itself in petrophysical interpretation, as well as in areas like prospect generation and evaluation, regional geologic studies, reservoir engineering/modeling, resistivity image processing and interpretation, and even sonic log processing and interpretation.
Needless to say, POLR’s capture of this crucial, high-fidelity data from WPA will be instrumental in determining pay intervals and prospective zones. This work should open up some strong secondary potential in the Vshale, net sand, and pay sand, with one of the longer-term goals being the construction of a deterministic log model for the local areas based on data constraints.
President and CEO of POLR, Daniel Walker, emphasized the breadth of experience and in-depth knowledge possessed by WPA, particularly regarding the geology and reservoir characteristics of the company’s targeted intervals. Walker forecast the development of improved stimulation strategies and production as the important end point of this log analysis work and expressed confidence that a better understanding of each reservoir would translate into long-term shareholder growth.
Wayne Campaign from WPA has been pegged as the study’s petrophysicist and he will be overseeing the extensive wireline log and petrophysical analysis. Two of the wells being looked at, the ARCO Pipeline State #1 and Hailstorm #1, are within POLR’s projects. The third, Burglin 33-1, is nearby, and the fourth, Hemi Springs State #1, while sunk just outside of POLR’s acreage, actually taps a target that is some 648 feet inside the company’s 40.7k-acre Hemi Springs Project (lease ADL391544).
Hemi Springs (100% WI, 80% NRI, 4% carried interest to the seller) has a lot of potential in its 16 leases and initial estimates are around 558M bbls of total recoverable petroleum reserves, with the conventional play stretching along the southwestern border of the Prudhoe Bay Unit. Franklin Bluffs (100% WI, 4% carried interest to the seller) is a 5.7k-acre patch consisting of one lease targeting an unconventional shale oil play surrounded by Great Bear Petroleum’s 500k plus acre lease position (purchased in 2010).
POLR intends to hit markets as soon as the data comes in and will be progressing sequentially through the wells, falling back on public domain wireline log data (stuff like the AOGCC digital archives and etc.) to help flesh out the collection phase. WPA will handle the quality control and log data editing to accurately tune for depth corrections and the like, with full reports being generated for each well evaluation, including the relevant figures and displays, with results also captured as digital products for use by the company.
To learn more about Polar Petroleum Corp., visit www.PolarPetro.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
This is a huge boon for POLR to strike such a deal with WPA, who is well-known throughout Alaska (their base of operations) and Texas for their comprehensive oil and gas services portfolio, spanning the operational spectrum with personnel that also have vast experience on the E&P and research end of things. These guys handle everything from development and wellsite geology, to geological and geophysical interpretation, as well as geosteering and log editing with full quality control. WPA offers some of the best minds in the business and is making a name for itself in petrophysical interpretation, as well as in areas like prospect generation and evaluation, regional geologic studies, reservoir engineering/modeling, resistivity image processing and interpretation, and even sonic log processing and interpretation.
Needless to say, POLR’s capture of this crucial, high-fidelity data from WPA will be instrumental in determining pay intervals and prospective zones. This work should open up some strong secondary potential in the Vshale, net sand, and pay sand, with one of the longer-term goals being the construction of a deterministic log model for the local areas based on data constraints.
President and CEO of POLR, Daniel Walker, emphasized the breadth of experience and in-depth knowledge possessed by WPA, particularly regarding the geology and reservoir characteristics of the company’s targeted intervals. Walker forecast the development of improved stimulation strategies and production as the important end point of this log analysis work and expressed confidence that a better understanding of each reservoir would translate into long-term shareholder growth.
Wayne Campaign from WPA has been pegged as the study’s petrophysicist and he will be overseeing the extensive wireline log and petrophysical analysis. Two of the wells being looked at, the ARCO Pipeline State #1 and Hailstorm #1, are within POLR’s projects. The third, Burglin 33-1, is nearby, and the fourth, Hemi Springs State #1, while sunk just outside of POLR’s acreage, actually taps a target that is some 648 feet inside the company’s 40.7k-acre Hemi Springs Project (lease ADL391544).
Hemi Springs (100% WI, 80% NRI, 4% carried interest to the seller) has a lot of potential in its 16 leases and initial estimates are around 558M bbls of total recoverable petroleum reserves, with the conventional play stretching along the southwestern border of the Prudhoe Bay Unit. Franklin Bluffs (100% WI, 4% carried interest to the seller) is a 5.7k-acre patch consisting of one lease targeting an unconventional shale oil play surrounded by Great Bear Petroleum’s 500k plus acre lease position (purchased in 2010).
POLR intends to hit markets as soon as the data comes in and will be progressing sequentially through the wells, falling back on public domain wireline log data (stuff like the AOGCC digital archives and etc.) to help flesh out the collection phase. WPA will handle the quality control and log data editing to accurately tune for depth corrections and the like, with full reports being generated for each well evaluation, including the relevant figures and displays, with results also captured as digital products for use by the company.
To learn more about Polar Petroleum Corp., visit www.PolarPetro.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Ventripoint Diagnostics Ltd. (VPTDF) Appoints New Vice-President of Sales and Marketing
Ventripoint Diagnostics today reported the appointment of Mr. Jerry Gatewood as its Vice-President of Sales and Marketing.
Gatewood brings more than 18 years of introducing new medical products with extensive experience in sales and marketing of imaging equipment. He was Global Market Manager for ATL Ultrasound (now Philips Medical Systems), where he created and executed global marketing and market introduction plans, and Director of U.S. Marketing for SonoSite (now part of FujiFilm) where he managed the U.S. marketing team and identified and developed new markets. He was also Director for Global Sales for Merge CAD, where he established, negotiated, and managed all aspects of original equipment manufacturer (OEM) partnerships, while securing national U.S. account agreements with major group purchasing organizations.
“It is with great pleasure that I welcome Jerry to the team” said Dr. George Adams, CEO of Ventripoint. “Jerry’s ‘been-there-done-that’ wisdom will lead us as we prepare for expanding sales into the U.S. and the rest of the world.”
“I am very excited at the opportunity to be a part of the Ventripoint team. This Company and its technology have a great potential to positively impact patient care and I am proud to be part of that movement” said Jerry Gatewood, VP of Sales and Marketing.
Mr. Amol Karnick will continue to be a consultant to the company and focus on Business Development.
For additional information, visit www.VentriPoint.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Gatewood brings more than 18 years of introducing new medical products with extensive experience in sales and marketing of imaging equipment. He was Global Market Manager for ATL Ultrasound (now Philips Medical Systems), where he created and executed global marketing and market introduction plans, and Director of U.S. Marketing for SonoSite (now part of FujiFilm) where he managed the U.S. marketing team and identified and developed new markets. He was also Director for Global Sales for Merge CAD, where he established, negotiated, and managed all aspects of original equipment manufacturer (OEM) partnerships, while securing national U.S. account agreements with major group purchasing organizations.
“It is with great pleasure that I welcome Jerry to the team” said Dr. George Adams, CEO of Ventripoint. “Jerry’s ‘been-there-done-that’ wisdom will lead us as we prepare for expanding sales into the U.S. and the rest of the world.”
“I am very excited at the opportunity to be a part of the Ventripoint team. This Company and its technology have a great potential to positively impact patient care and I am proud to be part of that movement” said Jerry Gatewood, VP of Sales and Marketing.
Mr. Amol Karnick will continue to be a consultant to the company and focus on Business Development.
For additional information, visit www.VentriPoint.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Immunomedics, Inc. (IMMU) Provides Update on Antibody-Drug Conjugate Programs at New York Biotechnology Association Conference
Biopharmaceutical company Immunomedics announced that the company’s president and CEO, Cynthia L. Sullivan, provided an update on Immunomedics’ antibody-drug conjugate (ADC) programs during the company’s presentation at the New York Biotechnology Association’s Annual Meeting on May 29, 2013.
Immunomedics currently has three ADCs in clinical development, but recent results are especially encouraging from the two being studied in patients with advanced solid tumors – particularly metastatic colorectal and triple-negative breast cancers. Tumor shrinkage, including partial responses determined by RECIST criteria, was achieved in dose-escalation trials of IMMU-130 and IMMU-132 ADC product candidates.
Both ADC product candidates involve SN-38, which is the active metabolite of irinotecan – used in treating metastatic colorectal and other cancers – conjugated by Immunomedics’ proprietary technology to labetuzumab (anti-CEACAM5 humanized monoclonal antibody; IMMU-130) or the anti-TROP-2 humanized antibody, hRS7 (IMMU-132). IMMU-130 is being studied in advanced colorectal cancer patients who have failed irinotecan therapy, while IMMU-132 is being tested in 13 types of cancer, including colorectal, triple-negative breast, bladder, pancreas, prostate, kidney, and ovarian.
“Since we have seen tumor shrinkage, including partial responses, so early in these trials, and that SN-38 bound to two different antibodies has been active, our confidence is increased regarding the future potential of these ADC candidates for treating these major cancer types after they become refractive to conventional chemotherapeutic agents,” Sullivan said. “The major toxicities, to date, have been diarrhea and neutropenia, which generally can be alleviated by other medications, and these appear to be less frequent and milder than with irinotecan therapy.”
Sullivan added that the Phase Ib trial of 90Y-clivatuzumab tetraxetan in patients with advanced, third-line pancreatic cancer is nearing completion of follow-up, and analysis of survival results is continuing. The trial compared clivatuzumab alone with the combination of clivatuzumab with low-dose gemcitabine in an open-label, randomized trial.
For more information, visit www.immunomedics.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Immunomedics currently has three ADCs in clinical development, but recent results are especially encouraging from the two being studied in patients with advanced solid tumors – particularly metastatic colorectal and triple-negative breast cancers. Tumor shrinkage, including partial responses determined by RECIST criteria, was achieved in dose-escalation trials of IMMU-130 and IMMU-132 ADC product candidates.
Both ADC product candidates involve SN-38, which is the active metabolite of irinotecan – used in treating metastatic colorectal and other cancers – conjugated by Immunomedics’ proprietary technology to labetuzumab (anti-CEACAM5 humanized monoclonal antibody; IMMU-130) or the anti-TROP-2 humanized antibody, hRS7 (IMMU-132). IMMU-130 is being studied in advanced colorectal cancer patients who have failed irinotecan therapy, while IMMU-132 is being tested in 13 types of cancer, including colorectal, triple-negative breast, bladder, pancreas, prostate, kidney, and ovarian.
“Since we have seen tumor shrinkage, including partial responses, so early in these trials, and that SN-38 bound to two different antibodies has been active, our confidence is increased regarding the future potential of these ADC candidates for treating these major cancer types after they become refractive to conventional chemotherapeutic agents,” Sullivan said. “The major toxicities, to date, have been diarrhea and neutropenia, which generally can be alleviated by other medications, and these appear to be less frequent and milder than with irinotecan therapy.”
Sullivan added that the Phase Ib trial of 90Y-clivatuzumab tetraxetan in patients with advanced, third-line pancreatic cancer is nearing completion of follow-up, and analysis of survival results is continuing. The trial compared clivatuzumab alone with the combination of clivatuzumab with low-dose gemcitabine in an open-label, randomized trial.
For more information, visit www.immunomedics.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Timing is Perfect for Loans4Less.com, Inc. (LFLS)
History can be a dependable teacher and guardian, protecting us from repeating mistakes and pointing to important opportunities that can otherwise go unnoticed. But history ignored is powerless, and those unwilling to study the past will always face an uncertain future. It’s a lesson confirmed most recently by America’s real estate collapse, a financial catastrophe that resulted in nearly 4 million foreclosures across the country. More than numbers, each foreclosure was a personal disaster for those who went through it, sometimes ruining marriages, breaking up families, and leaving scars that could last generations.
It’s easy to point to the economists and financial leaders that should have known better, people who, fueled by a mix of greed and irresponsibility, willingly packaged loans that were purely speculative. By so doing, they were effectively selling a car without brakes, making a crash not only probable, but virtually unavoidable. And yet a simple glance at history could have prepared anyone, regardless of their financial training.
Over the past 60 years, existing U.S. home prices, adjusted for inflation, can be seen to have remained largely steady, with small scale booms toward the end of the 1970s and the 1980s. In those booms, a house for $100,000 might have jumped to $115,000 on average, although some areas spiked more than others. Then, beginning around 2000, a price rush started like no other in American history. By 2006 prices had gone off the charts. Instead of a $100,000 house jumping to $115,000, it was suddenly exploding to $200,000, multiples of any previous boom, with prices in some areas far exceeding even that. Like walking the gentle hills of Iowa and suddenly coming across Mount Everest, it’s hard to imagine that anyone could not anticipate the massive readjustment that would inevitably come.
Few would ever want to see a repeat of such an earthquake. With a stricter mortgage environment and reduced housing inventory, some are surprised that housing prices are once again on the upswing, but to a much more modest degree. For California-based online mortgage broker Loans4Less.com, this new and steady growth is providing the perfect foundation for their own development and expansion. The company is rapidly building what it predicts will be an extensively used nationwide platform for real estate and mortgage partners across the country. They’ve created an easy-to-use comprehensive online environment for consumers seeking mortgage and real estate information, a platform that can be leveraged by others to ultimately form a central portal for the industry. With 80% of all home buyers using the Internet for their house hunting, and housing demand continuing to rise, the timing couldn’t be better.
For more information, visit www.Loans4Less.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
It’s easy to point to the economists and financial leaders that should have known better, people who, fueled by a mix of greed and irresponsibility, willingly packaged loans that were purely speculative. By so doing, they were effectively selling a car without brakes, making a crash not only probable, but virtually unavoidable. And yet a simple glance at history could have prepared anyone, regardless of their financial training.
Over the past 60 years, existing U.S. home prices, adjusted for inflation, can be seen to have remained largely steady, with small scale booms toward the end of the 1970s and the 1980s. In those booms, a house for $100,000 might have jumped to $115,000 on average, although some areas spiked more than others. Then, beginning around 2000, a price rush started like no other in American history. By 2006 prices had gone off the charts. Instead of a $100,000 house jumping to $115,000, it was suddenly exploding to $200,000, multiples of any previous boom, with prices in some areas far exceeding even that. Like walking the gentle hills of Iowa and suddenly coming across Mount Everest, it’s hard to imagine that anyone could not anticipate the massive readjustment that would inevitably come.
Few would ever want to see a repeat of such an earthquake. With a stricter mortgage environment and reduced housing inventory, some are surprised that housing prices are once again on the upswing, but to a much more modest degree. For California-based online mortgage broker Loans4Less.com, this new and steady growth is providing the perfect foundation for their own development and expansion. The company is rapidly building what it predicts will be an extensively used nationwide platform for real estate and mortgage partners across the country. They’ve created an easy-to-use comprehensive online environment for consumers seeking mortgage and real estate information, a platform that can be leveraged by others to ultimately form a central portal for the industry. With 80% of all home buyers using the Internet for their house hunting, and housing demand continuing to rise, the timing couldn’t be better.
For more information, visit www.Loans4Less.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Advaxis, Inc. (ADXS) Establishes Blueprint for 2013 Business Achievements
Advaxis is a clinical-stage biotech company with a centralized focus on its candidate, ADXS-HPV, which is being evaluated in five clinical trials for HPV-associated diseases: recurrent/refractory cervical cancer, locally advanced cervical cancer, head and neck cancer, and anal cancer.
In its recent 2013 business outlook, Advaxis said it is pursuing two overarching objectives for 2013 – to advance ADXS-HPV toward registration and development, and to strengthen its financial position – paired with supporting clinical regulatory objectives which are to analyze phase 2 data, proceed with and finalize its clinical plan, and to consult with regulatory authorities to advance ADXS-HPV to registrational trials.
In 2012 the company began laying serious groundwork to achieve its mission for 2013, securing a $10 million committed equity line, slashing its debt by 80 percent, and achieving proof of concept for ADXS-HPV.
So far this year, the company has dosed its first patient in a phase 1/2 study of ADXS-HPV in 25 patients with HPV-associated anal cancer .This study expands the clinical investigation of ADXS-HPV to now a third tumor type, following cervical cancer and head and neck cancer.
The company also recently took a step toward its first licensing deal, announcing that it is working to establish a formal agreement with FusionVax, Inc., a private Taiwan-based biopharmaceutical company developing immunotherapies for the treatment of HPV-associated cancers. Upon final agreement, Advaxis will exclusively license the rights to ADXS-HPV to FusionVax for the Asia territory, exclusive of India, for all indications.
For the remainder of 2013, Advaxis is on deck to achieve several expectations:
• Announce CIN 2/3 mid-dose cohort 2 data (Q2)
• Announce 12-month survival data from India study (Q2)
• Announce final phase 2 cervical cancer results (H2)
• Initiate phase 2 high-dose cohort 3 CIN 2/3
• Complete safety portion of ADXS-cHER2 phase ½ canine study (year-end)
• Report preliminary data from canine study
In the first six months of 2014, Advaxis anticipates that it will be prepared to file and IND with the FDA for ADXS-PSA.
For more information visit www.advaxis.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
In its recent 2013 business outlook, Advaxis said it is pursuing two overarching objectives for 2013 – to advance ADXS-HPV toward registration and development, and to strengthen its financial position – paired with supporting clinical regulatory objectives which are to analyze phase 2 data, proceed with and finalize its clinical plan, and to consult with regulatory authorities to advance ADXS-HPV to registrational trials.
In 2012 the company began laying serious groundwork to achieve its mission for 2013, securing a $10 million committed equity line, slashing its debt by 80 percent, and achieving proof of concept for ADXS-HPV.
So far this year, the company has dosed its first patient in a phase 1/2 study of ADXS-HPV in 25 patients with HPV-associated anal cancer .This study expands the clinical investigation of ADXS-HPV to now a third tumor type, following cervical cancer and head and neck cancer.
The company also recently took a step toward its first licensing deal, announcing that it is working to establish a formal agreement with FusionVax, Inc., a private Taiwan-based biopharmaceutical company developing immunotherapies for the treatment of HPV-associated cancers. Upon final agreement, Advaxis will exclusively license the rights to ADXS-HPV to FusionVax for the Asia territory, exclusive of India, for all indications.
For the remainder of 2013, Advaxis is on deck to achieve several expectations:
• Announce CIN 2/3 mid-dose cohort 2 data (Q2)
• Announce 12-month survival data from India study (Q2)
• Announce final phase 2 cervical cancer results (H2)
• Initiate phase 2 high-dose cohort 3 CIN 2/3
• Complete safety portion of ADXS-cHER2 phase ½ canine study (year-end)
• Report preliminary data from canine study
In the first six months of 2014, Advaxis anticipates that it will be prepared to file and IND with the FDA for ADXS-PSA.
For more information visit www.advaxis.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Primco Management Inc. (PMCM) Announces the Acquisition of Top Sail Productions
Parent company of ESMG Inc., Primco Management, a fully integrated multi-media entertainment company that includes its music label ES Music, stated the closing and full funding of acquisition of Top Sail Productions. Top Sail is a music production company and record label with a multi-year United States distribution deal through WEA, a Warner Music Group Company. Music industry veteran Chuck Gullo, principal of Top Sail Productions, will continue on as a Senior Executive Consultant in order to assist in the management and operations of Top Sail Productions.
Since founding in 1999, Top Sail Productions has created a decade relevant CD series in partnership with well-known entertainment icon, Casey Kasem. Each CD in the Top 10 hits driven compilation series. Sales from the Casey Kasem compilation series have well exceeded two million units which totals to about $20 million in overall revenue. Chuck Gullo, whom will be staying on to assist with the project and the ESMG and PRIMCO teams will be reporting to David Michery, President and CEO of Primco Management Inc. Top Sail Productions is currently preparing for the launch of the “America’s Top Ten Hits” concert series and a new debuting series titled ” The Artist Series”, which is currently in development stages.
By aligning ESMusic with Top Sail Production and WEA/ Warner Music Group, the merger will strengthen ESMusics overall presence in the music industry. ESMusic will be able to continue confidently expanding its music operations and in addition be able to provide the United States exposure its artists seek through the reach of being apart of the WEA Distribution family, a Warner Music Group Company. Chuck Gullo and David Michery, along with their strong team of entertainment executives, the staff at WEA Distribution, and a winning strategy, will make for a remarkable combination that will lead profitable music production goals and meet national distribution needs.
“I am very excited and pleased to be part of the new ESMG/PRIMCO family. I have worked with David Michery for many years. We have enjoyed some great success together in the industry and I expect that to continue with this new and exciting venture. We bring an established and innovative music catalog and product stream to ESMusic, as well as a proven and highly successful music management team. I look forward to continuing to work with WEA/Warner Music Group’s top management to maximize revenues and profits from the combined music distribution of Top Sail and ESMusic artists,” commented Chuck Gullo, President and CEO of Top Sail Productions.
“We warmly welcome music entrepreneur and longtime friend Chuck Gullo into the ESMG Music family and know that the combination of our respective music expertise and teams, with their veteran expertise, will result in a highly successful and mutually rewarding relationship. We look forward to working with Top Sail Productions to ramp up the production and marketing of the “America’s Top Ten Hits” brand and distribute new and commercially attractive music for many years to come,” stated Primco Management’s President and CEO, David Michery.
For more information, visit www.esmgusa.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Since founding in 1999, Top Sail Productions has created a decade relevant CD series in partnership with well-known entertainment icon, Casey Kasem. Each CD in the Top 10 hits driven compilation series. Sales from the Casey Kasem compilation series have well exceeded two million units which totals to about $20 million in overall revenue. Chuck Gullo, whom will be staying on to assist with the project and the ESMG and PRIMCO teams will be reporting to David Michery, President and CEO of Primco Management Inc. Top Sail Productions is currently preparing for the launch of the “America’s Top Ten Hits” concert series and a new debuting series titled ” The Artist Series”, which is currently in development stages.
By aligning ESMusic with Top Sail Production and WEA/ Warner Music Group, the merger will strengthen ESMusics overall presence in the music industry. ESMusic will be able to continue confidently expanding its music operations and in addition be able to provide the United States exposure its artists seek through the reach of being apart of the WEA Distribution family, a Warner Music Group Company. Chuck Gullo and David Michery, along with their strong team of entertainment executives, the staff at WEA Distribution, and a winning strategy, will make for a remarkable combination that will lead profitable music production goals and meet national distribution needs.
“I am very excited and pleased to be part of the new ESMG/PRIMCO family. I have worked with David Michery for many years. We have enjoyed some great success together in the industry and I expect that to continue with this new and exciting venture. We bring an established and innovative music catalog and product stream to ESMusic, as well as a proven and highly successful music management team. I look forward to continuing to work with WEA/Warner Music Group’s top management to maximize revenues and profits from the combined music distribution of Top Sail and ESMusic artists,” commented Chuck Gullo, President and CEO of Top Sail Productions.
“We warmly welcome music entrepreneur and longtime friend Chuck Gullo into the ESMG Music family and know that the combination of our respective music expertise and teams, with their veteran expertise, will result in a highly successful and mutually rewarding relationship. We look forward to working with Top Sail Productions to ramp up the production and marketing of the “America’s Top Ten Hits” brand and distribute new and commercially attractive music for many years to come,” stated Primco Management’s President and CEO, David Michery.
For more information, visit www.esmgusa.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Lpath, Inc. (LPTN) Issued Patent Related to Ocular Drug Program iSONEP
Lpath is a therapeutic antibody company and the category leader in lipid-targeted therapeutics. The company ImmuneY2 drug discovery engine has the unique ability to generate monoclonal antibodies that bind to and inhibit bioactive lipids that contribute to disease. Lpath has three drug candidates currently: Lpathomab, ASONEP, and iSONEP.
The company announced today that it has received official notification from the U.S. Patent and Trademark Office that it has been issued a key patent supporting its iSONEP program. The new patent claims methods of using monoclonal antibodies (including iSONEP) that bind sphingosine-1-phosphate (S1P) in the treatment of a wide variety of ocular conditions, including wet AMD (age-related macular degeneration). The company has a similar patent in Europe.
Lpath is currently conducting a Phase II clinical trial for iSONEP, called Nexus, which is evaluating the anti-S1P antibody’s safety and efficacy in wet-AMD patients. In 2010, the company entered into an agreement with drug giant Pfizer that provides Pfizer an exclusive option for worldwide license to develop and commercialize iSONEP.
The company is also conducting a Phase II trial for ASONEP in renal cell carcinoma patients. Both iSONEP and ASONEP are formulations of sonepcizumab, a first-in-class therapeutic antibody against S1Pdeveloped using Lpath’s ImmuneY2. Antibodies developed using this discovery engine are designed to target bioactive signaling lipids that are involved in cancer, macular degeneration, and many other diseases.
For further information about Lpath, its ImmuneY2 discovery engine, and its drug candidates, please visit www.Lpath.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
The company announced today that it has received official notification from the U.S. Patent and Trademark Office that it has been issued a key patent supporting its iSONEP program. The new patent claims methods of using monoclonal antibodies (including iSONEP) that bind sphingosine-1-phosphate (S1P) in the treatment of a wide variety of ocular conditions, including wet AMD (age-related macular degeneration). The company has a similar patent in Europe.
Lpath is currently conducting a Phase II clinical trial for iSONEP, called Nexus, which is evaluating the anti-S1P antibody’s safety and efficacy in wet-AMD patients. In 2010, the company entered into an agreement with drug giant Pfizer that provides Pfizer an exclusive option for worldwide license to develop and commercialize iSONEP.
The company is also conducting a Phase II trial for ASONEP in renal cell carcinoma patients. Both iSONEP and ASONEP are formulations of sonepcizumab, a first-in-class therapeutic antibody against S1Pdeveloped using Lpath’s ImmuneY2. Antibodies developed using this discovery engine are designed to target bioactive signaling lipids that are involved in cancer, macular degeneration, and many other diseases.
For further information about Lpath, its ImmuneY2 discovery engine, and its drug candidates, please visit www.Lpath.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Rainbow Coral Corp. (RBCC) to Fuel Patient Demand for Personalized Medicine and Better Healthcare
Today before the opening bell, Rainbow Coral Corp. announced that it is making plans to empower patients to demand better care through both innovation and education as the company sets its sights on the fast-growing, $232 billion personalized medicine market.
By delivering new technologies in the sectors of the personalized medicine field expected to see the most growth, Rainbow Coral hopes to arm patients with more effective and efficient treatment options than ever before. But, according to today’s press release, bringing new ideas and products to the marketplace is only one piece of the company’s expansion strategy.
“Our ultimate goal is to help spur patient-driven demand for personalized medicine,” RBCC CEO Patrick Brown stated. “That requires not just delivering new innovations, but helping to educate patients on these promising new treatment options. That’s why we’re developing a comprehensive media and marketing strategy.”
PricewaterhouseCoopers projects that the personalized medicine market in the U.S. could grow to as much as $452 billion by 2015. One of the fastest-growing fields in the market is companion diagnostics, an area of RBCC’s focus, which could grow to as large as $42 billion by 2015, according to industry analysts TriMarkPublications.com.
For more information, visit www.rainbowbiosciences.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
By delivering new technologies in the sectors of the personalized medicine field expected to see the most growth, Rainbow Coral hopes to arm patients with more effective and efficient treatment options than ever before. But, according to today’s press release, bringing new ideas and products to the marketplace is only one piece of the company’s expansion strategy.
“Our ultimate goal is to help spur patient-driven demand for personalized medicine,” RBCC CEO Patrick Brown stated. “That requires not just delivering new innovations, but helping to educate patients on these promising new treatment options. That’s why we’re developing a comprehensive media and marketing strategy.”
PricewaterhouseCoopers projects that the personalized medicine market in the U.S. could grow to as much as $452 billion by 2015. One of the fastest-growing fields in the market is companion diagnostics, an area of RBCC’s focus, which could grow to as large as $42 billion by 2015, according to industry analysts TriMarkPublications.com.
For more information, visit www.rainbowbiosciences.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
VIASPACE, Inc. (VSPC) Signs Contract with Philippines-Based Sugar Milling Company for Giant King™ Grass Product
Today, VIASPACE announced that it has signed a Giant King™ Grass supply contract with Sagay Central, Inc. The initial payment has been received, and VIASPACE’s agronomist has already visited the Philippines to meet with Sagay.
VIASPACE’s innovative Giant KingTM Grass is low-carbon fuel for clean electricity generation and for environmentally friendly energy pellets; what’s more, it can be used as a feedstock for bio-methane production and for green cellulosic biofuels, biochemical, and biomaterials. The proprietary, high yield, biomass clean energy crop does not compete with or displace food production, setting VIASPACE apart from its industry competitors.
VIASPACE’s Chairman, Dr. Kevin Schewe, remarked, “We are delighted to announce this project and partnership with Sagay Central. Their expertise and experience with growing sugar cane makes them a perfect fit for growing Giant King Grass as a renewable, high-yielding, biomass platform. Although we are currently seen by investors as a penny stock company, VIASPACE is actively working with many different international companies and continues to diversely expand its global footprint. This is an exciting time of rapid growth and setting the stage for the future of VIASPACE and its shareholders.”
Located in Bacolod City, Negros Occidental, Sagay Central is a sugar milling and sugar growing company in the center of the Philippines sugar industry, producing about 150,000 tons of sugar each year. Since 1945, Sagay Central has been producing raw sugar, washed sugar, and specialty Muscavado sugar (amongst other products) for the domestic market and export.
Mr. Romie Cortez, President of Sagay Central, commented, “We are indeed very happy to be working with VIASPACE Inc. on this important biomass renewable energy project. This fits well with our goal of diversifying our sugar operations in order to remain competitive in this very difficult sugar business in the Philippines. We are looking forward to grow the VIASPACE Giant King Grass in our estate for energy production and for export to Korea and Japan.”
For more information on VIASPACE, Giant King™ Grass, visit www.VIASPACE.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
VIASPACE’s innovative Giant KingTM Grass is low-carbon fuel for clean electricity generation and for environmentally friendly energy pellets; what’s more, it can be used as a feedstock for bio-methane production and for green cellulosic biofuels, biochemical, and biomaterials. The proprietary, high yield, biomass clean energy crop does not compete with or displace food production, setting VIASPACE apart from its industry competitors.
VIASPACE’s Chairman, Dr. Kevin Schewe, remarked, “We are delighted to announce this project and partnership with Sagay Central. Their expertise and experience with growing sugar cane makes them a perfect fit for growing Giant King Grass as a renewable, high-yielding, biomass platform. Although we are currently seen by investors as a penny stock company, VIASPACE is actively working with many different international companies and continues to diversely expand its global footprint. This is an exciting time of rapid growth and setting the stage for the future of VIASPACE and its shareholders.”
Located in Bacolod City, Negros Occidental, Sagay Central is a sugar milling and sugar growing company in the center of the Philippines sugar industry, producing about 150,000 tons of sugar each year. Since 1945, Sagay Central has been producing raw sugar, washed sugar, and specialty Muscavado sugar (amongst other products) for the domestic market and export.
Mr. Romie Cortez, President of Sagay Central, commented, “We are indeed very happy to be working with VIASPACE Inc. on this important biomass renewable energy project. This fits well with our goal of diversifying our sugar operations in order to remain competitive in this very difficult sugar business in the Philippines. We are looking forward to grow the VIASPACE Giant King Grass in our estate for energy production and for export to Korea and Japan.”
For more information on VIASPACE, Giant King™ Grass, visit www.VIASPACE.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
DoMark International Inc. (DOMK) Unveils New iPad Accessory Targeting $2.3 Billion Market
DoMark International, a leading investment management company focused on patented or patent pending mass market consumer products, today announced that it has initiated the design development of its new revolutionary lightweight infrared and solar panel charger case with a built-in back up lithium battery for the Apple iPad.
The new accessory, called IRiPAD Charger, will be the second product developed by DoMark for the Apple iPad. Unlike other chargers, DoMark’s product utilizes patented infrared and solar technology designed to improve functionality for the heavy user. By taking advantage of new landmark technology and incorporating a sophisticated light-weight design, the company anticipates achieving great success in the $2.3 billion iPad accessories market.
DoMark has already developed an infrared/solar charger case for the Apple iPhone and Samsung Galaxy III and S4 Smartphones which are to be launched in August 2013. The company also recently invested in privately held Imagic Ltd., which has produced a pioneering product for the gaming enthusiast with a planned launch for the Christmas season this year.
DoMark invests and develops in next-generation mass market consumer products for the explosive global Smartphone market, competing against Quantum International Corporation (QUAN) and Dover Corp. (DOV).
“This new product will add to the Company’s exciting new range of innovative products,” DoMarks Chief Executive Officer stated. “This is an exciting time for DoMark as our range of products are very well positioned to maximize global sales in this ever expanding market place”.
For more information on DoMark International, visit www.domarkintl.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
The new accessory, called IRiPAD Charger, will be the second product developed by DoMark for the Apple iPad. Unlike other chargers, DoMark’s product utilizes patented infrared and solar technology designed to improve functionality for the heavy user. By taking advantage of new landmark technology and incorporating a sophisticated light-weight design, the company anticipates achieving great success in the $2.3 billion iPad accessories market.
DoMark has already developed an infrared/solar charger case for the Apple iPhone and Samsung Galaxy III and S4 Smartphones which are to be launched in August 2013. The company also recently invested in privately held Imagic Ltd., which has produced a pioneering product for the gaming enthusiast with a planned launch for the Christmas season this year.
DoMark invests and develops in next-generation mass market consumer products for the explosive global Smartphone market, competing against Quantum International Corporation (QUAN) and Dover Corp. (DOV).
“This new product will add to the Company’s exciting new range of innovative products,” DoMarks Chief Executive Officer stated. “This is an exciting time for DoMark as our range of products are very well positioned to maximize global sales in this ever expanding market place”.
For more information on DoMark International, visit www.domarkintl.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Medient Studios, Inc. (MDNT) to Partner with Atlas
Global film production and distribution company Medient Studios announced that it has entered into a memorandum of understanding (MOU) with Atlas International Film GmbH, under which the Germany-based Atlas will act as sales agent for Medient’s initial slate of movies.
Under the terms of the MOU, Atlas will provide a sales advance of up to $30 million to form a portion of the financing for the movies in the slate. It is anticipated that Medient’s annual output will reach between eight and 12 movies, with budgets ranging from $2 million to $40 million. The MOU consolidates Atlas’ relationship with Medient and will further add a consistent flow of quality movies to the extensive products already exploited by Atlas.
“Atlas has a long and proud history of marketing and selling movies and we are delighted that it shares our vision,” said Medient Chairman and CEO Manu Kumaran. “The formalization of this relationship is one step further in creating the circle of strategic alliances to realize the mega-studio complex in Effingham, GA.”
Atlas was founded by the Menz family in 1967, and the company’s core business is the global licensing of feature films, series, and documentaries for all media. The Menz family additionally owns American Atlas International Films, Inc. as well as the production companies Atlas Film & TV Production GmbH and Menz & Friends GmbH.
A publicly listed global film production and distribution company, Medient has a strong presence in North America and India – the two largest movie markets in the world. The company’s management team boasts around 150 years of experience in the motion picture industry and has produced and/or financed more than 250 movies. Around 14 movies, two music acts, and several hundred live performance shows have also been produced under the Medient banner. Medient is currently in the process of substantially scaling up its operations, including a planned entry into the electronic games sector.
For more information, visit www.medient.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Under the terms of the MOU, Atlas will provide a sales advance of up to $30 million to form a portion of the financing for the movies in the slate. It is anticipated that Medient’s annual output will reach between eight and 12 movies, with budgets ranging from $2 million to $40 million. The MOU consolidates Atlas’ relationship with Medient and will further add a consistent flow of quality movies to the extensive products already exploited by Atlas.
“Atlas has a long and proud history of marketing and selling movies and we are delighted that it shares our vision,” said Medient Chairman and CEO Manu Kumaran. “The formalization of this relationship is one step further in creating the circle of strategic alliances to realize the mega-studio complex in Effingham, GA.”
Atlas was founded by the Menz family in 1967, and the company’s core business is the global licensing of feature films, series, and documentaries for all media. The Menz family additionally owns American Atlas International Films, Inc. as well as the production companies Atlas Film & TV Production GmbH and Menz & Friends GmbH.
A publicly listed global film production and distribution company, Medient has a strong presence in North America and India – the two largest movie markets in the world. The company’s management team boasts around 150 years of experience in the motion picture industry and has produced and/or financed more than 250 movies. Around 14 movies, two music acts, and several hundred live performance shows have also been produced under the Medient banner. Medient is currently in the process of substantially scaling up its operations, including a planned entry into the electronic games sector.
For more information, visit www.medient.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
ScripsAmerica, Inc. (SCRC) Inks Manufacturing, Distribution Deal with Capricorn Pharma to Prepare for Product Launch
ScripsAmerica, a leading supplier of prescription, OTC, and nutraceutical drugs for retail pharmacies, hospitals, long-term care facilities, and government and home care agencies, has signed an agreement with Capricorn Pharma, Inc. (CPI) for the development, manufacturing, and supply of ScripsAmerica’s RapiMed® children’s pain reliever and fever reducer.
CPI will manufacture and distribute RapiMed® within the U.S. and North America under an initial two-year contract with two five-year extension options. Terms of the agreement call for CPI to manufacture and distribute a minimum of 20 million tablets; both parties expect annual production growth with a projected volume of approximately 97 million RapiMed® tablets being distributed in the agreement’s seventh year.
ScripsAmerica anticipates launching its RapiMed® product in September of this year, and company CEO Bob Schneiderman emphasized the value he expects CPI to generate for the product roll-out.
“This is an exciting and important development for the company as we prepare for our anticipated RapiMed® product launch later this year. CPI is a very reputable manufacturer in the generic drug market and we are confident that our relationship will be very productive and beneficial for ScripsAmerica and its shareholders,” he stated in the press release.
For more information visit www.ScripsAmerica.com or www.capricornpharma.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
CPI will manufacture and distribute RapiMed® within the U.S. and North America under an initial two-year contract with two five-year extension options. Terms of the agreement call for CPI to manufacture and distribute a minimum of 20 million tablets; both parties expect annual production growth with a projected volume of approximately 97 million RapiMed® tablets being distributed in the agreement’s seventh year.
ScripsAmerica anticipates launching its RapiMed® product in September of this year, and company CEO Bob Schneiderman emphasized the value he expects CPI to generate for the product roll-out.
“This is an exciting and important development for the company as we prepare for our anticipated RapiMed® product launch later this year. CPI is a very reputable manufacturer in the generic drug market and we are confident that our relationship will be very productive and beneficial for ScripsAmerica and its shareholders,” he stated in the press release.
For more information visit www.ScripsAmerica.com or www.capricornpharma.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Leading Wuhan Supermarket Chain and Tianli Agritech, Inc. (OINK) Partner Up
Leading producer of breeder hogs, market hogs, and black hogs, Tianli Agritech announced that the company has signed a contractual agreement with Zhongbai Warehouse Supermarket Co., Ltd. (“ZHONGBAI”) to sell meat cuts of its Tianli-Xiduhei™ black hog product in five warehouse outlets held by ZHONGBAI’s in Wuhan, Hubei province. Tianli Agritech is currently headquartered in Wuhan City, China.
ZHONGBAI was first established in 1997 and is a wholly owned subsidiary of Zhongbai Holding Group Co. Ltd. (000759.SZ) (“Zhongbai Holding”), a leading supermarket chain in Wuhan. According to its latest Annual Report, Zhongbai Holding is stated to have 244 warehouses, 651 convenience stores, 5 department stores, and 45 electronics stores. Net sales of Zhongbai Holding totaled RMB 15.7 billion in 2012, of which ZHONGBAI produced about RMB 11.2 billion.
Chairwoman and CEO of Tianli Agritech, Hanying Li, commented, “We are very excited to see cuts of our branded black hog meat gain traction in the Wuhan market following our recent entry into the Beijing market. This marks an important milestone for our retail channel buildout effort and could potentially open the door for us to gain broader access to Zhongbai Holding’s network of stores. As we are committed to expand our reach in the Wuhan market and explore other geographic markets, we expect retail sales of our black hog products to generate meaningful revenue and earnings in coming quarters.”
Tianli’s black hogs and Tianli-Xiduhei™ meat cuts are items that are a part of the company’s “10,000 families and 1,000,000 Black Hogs” program in the Enshi Prefecture, Hubei Province. The company provided funds totaling $12.67 million and completed the construction of 765 black hog farms in Enshi Prefecture by March’s 2013 end.
To learn more, please visit www.weitian-ir.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
ZHONGBAI was first established in 1997 and is a wholly owned subsidiary of Zhongbai Holding Group Co. Ltd. (000759.SZ) (“Zhongbai Holding”), a leading supermarket chain in Wuhan. According to its latest Annual Report, Zhongbai Holding is stated to have 244 warehouses, 651 convenience stores, 5 department stores, and 45 electronics stores. Net sales of Zhongbai Holding totaled RMB 15.7 billion in 2012, of which ZHONGBAI produced about RMB 11.2 billion.
Chairwoman and CEO of Tianli Agritech, Hanying Li, commented, “We are very excited to see cuts of our branded black hog meat gain traction in the Wuhan market following our recent entry into the Beijing market. This marks an important milestone for our retail channel buildout effort and could potentially open the door for us to gain broader access to Zhongbai Holding’s network of stores. As we are committed to expand our reach in the Wuhan market and explore other geographic markets, we expect retail sales of our black hog products to generate meaningful revenue and earnings in coming quarters.”
Tianli’s black hogs and Tianli-Xiduhei™ meat cuts are items that are a part of the company’s “10,000 families and 1,000,000 Black Hogs” program in the Enshi Prefecture, Hubei Province. The company provided funds totaling $12.67 million and completed the construction of 765 black hog farms in Enshi Prefecture by March’s 2013 end.
To learn more, please visit www.weitian-ir.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Web Traffic at Pazoo.com, Inc. (PZOO) Triples From April to May
Yesterday, Pazoo announced that the total number of visitors to the Pazoo.com website had tripled during May of 2013, with over 340,000 hits versus April’s 113,647. The company has stated that site traffic would have been higher if not for a crash and subsequent site glitches during May.
Pazoo is focused on providing health and wellness information through its website and television, as well as advertising for products and services. The Pazoo.com website acts as a wellness social network that has, according to the company’s press release, “an array of experts delivering vital information to improve and enhance the enjoyment of living a full and enriching life.”
Pazoo has stated that it intends to “continue to create a favorable environment to generate high-end advertising” on their website, which, based on May’s traffic, will cause advertising revenue to increase proportionately. The company expects the website to reach profitability in the fourth quarter of 2013.
This will also be dependent on Pazoo implementing new technology that the company hopes will be able to manage the site’s traffic increase. The aforementioned issues with site crashing were due specifically to the increase of users visiting the site, and it is hoped that the new measures being taken will prevent future traffic-based problems from arising.
For more information, visit www.pazoo.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Pazoo is focused on providing health and wellness information through its website and television, as well as advertising for products and services. The Pazoo.com website acts as a wellness social network that has, according to the company’s press release, “an array of experts delivering vital information to improve and enhance the enjoyment of living a full and enriching life.”
Pazoo has stated that it intends to “continue to create a favorable environment to generate high-end advertising” on their website, which, based on May’s traffic, will cause advertising revenue to increase proportionately. The company expects the website to reach profitability in the fourth quarter of 2013.
This will also be dependent on Pazoo implementing new technology that the company hopes will be able to manage the site’s traffic increase. The aforementioned issues with site crashing were due specifically to the increase of users visiting the site, and it is hoped that the new measures being taken will prevent future traffic-based problems from arising.
For more information, visit www.pazoo.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
International Stem Cell Corp. (ISCO) Initiates Final Step to File IND for Treatment of Parkinson’s Disease
International Stem Cell, a biotech company focused on developing novel stem cell-based therapies, has initiated its IND-enabling pharmacology and toxicology non-human primate studies directed by Yale School of Medicine Professor D. Eugene Redmond Jr. MD, an internationally recognized neurosurgeon and a leader in the use of stem cells for the treatment of Parkinson’s disease.
The studies will assess the safety and efficacy of ISCO’s proprietary stem cell-derived neuronal cells when administered to non-human primates with moderate to severe Parkinson’s disease symptoms. Established endpoints of these multi-dose studies are to determine cell fate, biodistribution, and primate behavioral evaluations using a standardized rating scale to assess potential extrapyramidal side effects associated with the cell engraftment.
In his career of more than 25 years, Professor Redmond has become a recognized expert in the use of transplanted neural cells to treat parkinsonism in primates and the development of effective replacement strategies using stem cell derived neurons. In addition, he has established one of the first preclinical models for Parkinson’s disease in primates, the first successful transplantation of fetal tissue into the brain of a primate, and one of the first clinical studies of fetal tissue in Parkinson’s patients.
Dr. Ruslan Semechkin, vice president of ISCO’s R&D, referenced positive data from the company’s recent, successful primate and rodent studies, and said that under the leadership and knowledge of Professor Redmond, the upcoming formal studies will be final step for ISCO to file an IND for Parkinson’s disease.
“As one of the leaders in this field, it’s tremendously exciting for ISCO to have such an experienced and influential clinical scientist as Prof. Redmond to direct this research. His clinical experience will be invaluable as we prepare both our IND submission to the FDA and the subsequent phase I clinical trial,” Dr. Semechkin stated in the press release.
ISCO expects interim results in the fourth quarter of 2013 with the final results available in the second quarter of 2014.
For more information, visit www.internationalstemcell.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
The studies will assess the safety and efficacy of ISCO’s proprietary stem cell-derived neuronal cells when administered to non-human primates with moderate to severe Parkinson’s disease symptoms. Established endpoints of these multi-dose studies are to determine cell fate, biodistribution, and primate behavioral evaluations using a standardized rating scale to assess potential extrapyramidal side effects associated with the cell engraftment.
In his career of more than 25 years, Professor Redmond has become a recognized expert in the use of transplanted neural cells to treat parkinsonism in primates and the development of effective replacement strategies using stem cell derived neurons. In addition, he has established one of the first preclinical models for Parkinson’s disease in primates, the first successful transplantation of fetal tissue into the brain of a primate, and one of the first clinical studies of fetal tissue in Parkinson’s patients.
Dr. Ruslan Semechkin, vice president of ISCO’s R&D, referenced positive data from the company’s recent, successful primate and rodent studies, and said that under the leadership and knowledge of Professor Redmond, the upcoming formal studies will be final step for ISCO to file an IND for Parkinson’s disease.
“As one of the leaders in this field, it’s tremendously exciting for ISCO to have such an experienced and influential clinical scientist as Prof. Redmond to direct this research. His clinical experience will be invaluable as we prepare both our IND submission to the FDA and the subsequent phase I clinical trial,” Dr. Semechkin stated in the press release.
ISCO expects interim results in the fourth quarter of 2013 with the final results available in the second quarter of 2014.
For more information, visit www.internationalstemcell.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Wednesday, May 29, 2013
Centor, Inc. (CNTO) Expands Gold Footprint in Ghana, Exercises Achaa Concession Purchase Option
Centor is intelligently taking advantage of their own strong position, as well as external, consolidative forces in the resource sector to help build their already strong project portfolio (15.5 sq mile Nobewam project in the Kumasi basin, near the 4M oz Konongo mine) in Ghana’s rich, under-developed mineral base, and the company was pleased to report today that they have exercised their option to purchase the Achaa Mining Company concession at Anyinaso, just 18.5 miles south of Newmont’s Kenyasi mine.
The 10.3 square mile Anyinaso Concession lies in the heart of the prolific (and by now world-famous) Ashanti Gold Belt, which shows ankerite, calcite, magnesite, and siderite in all host and mineralized rocks (spec. Bogoso/Prestea mining districts). This is one of the key gold areas in the world right now and CNTO is cozied up alongside majors in the race to grab prime acreage, as a much smaller player with tremendous potential upside on their deposits for investors.
Initial recon and analytical exploration efforts on Anyinaso have yielded promising returns and CNTO management is confident that results will pan out handsomely during the 6-month window allowed under the option agreement for testing. In fact, CNTO is hard at work on the test program’s details right now, hammering out the profile of a rigorous soil sampling effort for one of the choice target areas, a nice big slice between the Offin Shelterbelt Forest Reserve and the Awontaso River.
More western Kumasi basin potential here for CNTO, just at the northern arm of the Safi Belt in territory that has been extensively looked at by Newmont and others, validating the mineralization potential in spades. We have some huge vectors here for not just structural contact, but all kinds of intrabasinal sediment and the property is up from the 300k oz (over seven years) alluvial, Jeni River Concession, meaning much of that gold potentially came out of the hard rock at Anyinaso. Not so far north as Newmont’s Kenyasi mine, about 4.3 miles north of Anyinaso, we have the site where Ashanti-Bibini open-pitted some 100k ounces of Au via the exceptional Mpesetia deposit.
Just to the southeast another four open pit operations, collectively, within the last decade have pulled out a whopping 30M tons at 2g/t and it seems certain that, given the structural similarities between the proximal open pit operations, the regional geology, and the initial Anyinaso findings, high confidence at CNTO is well-deserved about Anyinaso’s long-term profitability for shareholders. If production is in line with estimates based on these metrics, data coming out of the next phase of testing, for which CNTO is now poised, should impress both investor and shareholder alike.
You can take a look at the Terminal Report on Nobewam (PDF) and the Geological Report on Anyinaso (PDF), or get more general info on Centor, Inc., at www.CentorResources.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
The 10.3 square mile Anyinaso Concession lies in the heart of the prolific (and by now world-famous) Ashanti Gold Belt, which shows ankerite, calcite, magnesite, and siderite in all host and mineralized rocks (spec. Bogoso/Prestea mining districts). This is one of the key gold areas in the world right now and CNTO is cozied up alongside majors in the race to grab prime acreage, as a much smaller player with tremendous potential upside on their deposits for investors.
Initial recon and analytical exploration efforts on Anyinaso have yielded promising returns and CNTO management is confident that results will pan out handsomely during the 6-month window allowed under the option agreement for testing. In fact, CNTO is hard at work on the test program’s details right now, hammering out the profile of a rigorous soil sampling effort for one of the choice target areas, a nice big slice between the Offin Shelterbelt Forest Reserve and the Awontaso River.
More western Kumasi basin potential here for CNTO, just at the northern arm of the Safi Belt in territory that has been extensively looked at by Newmont and others, validating the mineralization potential in spades. We have some huge vectors here for not just structural contact, but all kinds of intrabasinal sediment and the property is up from the 300k oz (over seven years) alluvial, Jeni River Concession, meaning much of that gold potentially came out of the hard rock at Anyinaso. Not so far north as Newmont’s Kenyasi mine, about 4.3 miles north of Anyinaso, we have the site where Ashanti-Bibini open-pitted some 100k ounces of Au via the exceptional Mpesetia deposit.
Just to the southeast another four open pit operations, collectively, within the last decade have pulled out a whopping 30M tons at 2g/t and it seems certain that, given the structural similarities between the proximal open pit operations, the regional geology, and the initial Anyinaso findings, high confidence at CNTO is well-deserved about Anyinaso’s long-term profitability for shareholders. If production is in line with estimates based on these metrics, data coming out of the next phase of testing, for which CNTO is now poised, should impress both investor and shareholder alike.
You can take a look at the Terminal Report on Nobewam (PDF) and the Geological Report on Anyinaso (PDF), or get more general info on Centor, Inc., at www.CentorResources.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Solar Wind Energy, Inc. (SWET) Puts a Brilliant Spin on an Ancient Idea
Windcatchers represent an ancient technology still used today in parts of the Middle East and other dry regions of the world. Windcatchers are designed to create natural dwelling ventilation and, when used with water pads, a natural cooling effect. It consists of a tower that rises above the dwelling, with an opening that catches the passing wind. The wind is carried down into the dwelling, providing a refreshing breeze to push out stagnant hot air. When pads dampened with water are used to line the tower, the moving dry air evaporates the moisture, which causes a drop in air temperature and increased density. The heavy cool air shoots down the tower and through the dwelling, enhancing the ventilation and cooling.
Today, this time-tested concept is being used in an entirely different way, providing a new highly-efficient source of clean plentiful energy. Solar Wind Energy, a Maryland-based renewable energy company, has developed what is called a solar wind downdraft tower. Their proprietary tower, currently in the final stages of patenting, is uniquely designed to capture the power of both sun and moving air.
As with a windcatcher, the wind is captured by the tower, but then the air’s motion is greatly increased by tapping the solar generated heat energy carried in the air. As water is introduced to the dry air within the confines of the tower structure, it immediately evaporates, creating a massive downdraft with the cool dense air plummeting downward at speeds that can exceed 50 miles per hour. At the base, the energy from all that moving air is quickly captured, while the water is recycled for continued use. The net result, after all factors are considered, is calculated to be approximately 400-500 megawatt hours, depending upon conditions, available for sale to the grid.
For information on Solar Wind Energy visit www.cleanwindenergytower.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Today, this time-tested concept is being used in an entirely different way, providing a new highly-efficient source of clean plentiful energy. Solar Wind Energy, a Maryland-based renewable energy company, has developed what is called a solar wind downdraft tower. Their proprietary tower, currently in the final stages of patenting, is uniquely designed to capture the power of both sun and moving air.
As with a windcatcher, the wind is captured by the tower, but then the air’s motion is greatly increased by tapping the solar generated heat energy carried in the air. As water is introduced to the dry air within the confines of the tower structure, it immediately evaporates, creating a massive downdraft with the cool dense air plummeting downward at speeds that can exceed 50 miles per hour. At the base, the energy from all that moving air is quickly captured, while the water is recycled for continued use. The net result, after all factors are considered, is calculated to be approximately 400-500 megawatt hours, depending upon conditions, available for sale to the grid.
For information on Solar Wind Energy visit www.cleanwindenergytower.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
The Aristocrat Group Corp. (ASCC) Announces Big Plans for Growth
Aristocrat Group is preparing for aggressive growth in 2013, with its debut vodka brand slated for release in only a few short weeks, and it’s investing in a new packaging innovation that could help expand its beverage line. The company also has plans to distribute its beverages nationwide in order to compete in the highly profitable top-shelf spirits sector, an industry that includes LVMH Moet Hennessy Louis Vuitton, Diageo PLC, BEAM Inc., and Brown-Forman Corp.
ASCC’s first plan of action is to take its gluten-free RWB Ultra-Premium Handcrafted Vodka to the marketplace this summer. The company is currently in talks with clubs and venues in Las Vegas and Los Angeles to host official premiere events, which will pave the way for additional products to come.
The company is extremely excited to deliver a top-shelf spirit to the United States’ booming $5.5 billion vodka market, but RWB is only the start of its plans. Later this year, ASCC will release a second vodka brand that features a packaging innovation with the potential to turn the industry on its head.
Robert Federowicz, ASCC’s CEO, remarked, “This is an eye-catching, functional design that’s going to stand out on the shelves. It’s something that we can apply to niche products like high-end tequila, custom spirits and imported microbrews in addition to vodka. We can’t wait to release additional details as soon as our patent application is approved.”
For more information, visit www.aristocratgroupcorp.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
ASCC’s first plan of action is to take its gluten-free RWB Ultra-Premium Handcrafted Vodka to the marketplace this summer. The company is currently in talks with clubs and venues in Las Vegas and Los Angeles to host official premiere events, which will pave the way for additional products to come.
The company is extremely excited to deliver a top-shelf spirit to the United States’ booming $5.5 billion vodka market, but RWB is only the start of its plans. Later this year, ASCC will release a second vodka brand that features a packaging innovation with the potential to turn the industry on its head.
Robert Federowicz, ASCC’s CEO, remarked, “This is an eye-catching, functional design that’s going to stand out on the shelves. It’s something that we can apply to niche products like high-end tequila, custom spirits and imported microbrews in addition to vodka. We can’t wait to release additional details as soon as our patent application is approved.”
For more information, visit www.aristocratgroupcorp.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Raptor Resources Holdings Inc. (RRHI) is “One to Watch”
Raptor Resources Holdings is a publicly traded holdings company focused on mineral resource acquisition, exploration, and development. The company currently has two subsidiaries: Mabwe Minerals Inc. (MBMI), a natural resources and hard asset company engaged in the mining and commercial sales of industrial minerals & metals with first focus on barite; and TAG Minerals Inc., a mineral & metal resource acquisition, exploration, and development company with first focus on alluvial surface gold.
Mabwe Minerals has been the focus of the parent company’s efforts the last two years to move into commercial barite production. RRHI shareholders share a common interest with MBMI shareholders in the success of Dodge Mine as the parent company owns 90M shares of MBMI. The Dodge Mine property consists of three hydrothermal mountains representing 123 hectares containing multiple deposits of superior-grade barite, limestone, and talc.
TAG Minerals, along with its indigenous affiliate, TAG Minerals Zimbabwe (Private) Limited, is responsible for alluvial gold production along with the development of greenfield assets targeting bedrock gold and other potential metals & minerals. As MBMI is transitioning into commercial barite production, RRHI will now focus on building assets within TAG Minerals with the intent of moving into commercial production within the next 18 months. TAG Minerals will utilize the latest in Heavy Particle Concentrators (HPC-30/HPC-100) through its relationship with Extrac-TEC whose gold recovery and mineral separation technology captures up to 98% of alluvial gold down to 50 microns. The company is in early stage exploration evaluating potential alluvial sites to ensure they meet the company’s criteria for commercial production. Coupled with MBMI’s acquisition of WGB Kinsey & Company, TAG Minerals is well positioned to fast track into commercial production once the company has successfully completed its exploratory testing.
RRHI management continues to improve its balance sheet as reflected in the company’s SEC 10k filing, including favorable reductions in the company’s debt/liabilities and securing 54.4M shares and 14.4M warrants of RRHI from prior employees. The company is committed to growing its asset base in TAG Minerals moving forward.
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Mabwe Minerals has been the focus of the parent company’s efforts the last two years to move into commercial barite production. RRHI shareholders share a common interest with MBMI shareholders in the success of Dodge Mine as the parent company owns 90M shares of MBMI. The Dodge Mine property consists of three hydrothermal mountains representing 123 hectares containing multiple deposits of superior-grade barite, limestone, and talc.
TAG Minerals, along with its indigenous affiliate, TAG Minerals Zimbabwe (Private) Limited, is responsible for alluvial gold production along with the development of greenfield assets targeting bedrock gold and other potential metals & minerals. As MBMI is transitioning into commercial barite production, RRHI will now focus on building assets within TAG Minerals with the intent of moving into commercial production within the next 18 months. TAG Minerals will utilize the latest in Heavy Particle Concentrators (HPC-30/HPC-100) through its relationship with Extrac-TEC whose gold recovery and mineral separation technology captures up to 98% of alluvial gold down to 50 microns. The company is in early stage exploration evaluating potential alluvial sites to ensure they meet the company’s criteria for commercial production. Coupled with MBMI’s acquisition of WGB Kinsey & Company, TAG Minerals is well positioned to fast track into commercial production once the company has successfully completed its exploratory testing.
RRHI management continues to improve its balance sheet as reflected in the company’s SEC 10k filing, including favorable reductions in the company’s debt/liabilities and securing 54.4M shares and 14.4M warrants of RRHI from prior employees. The company is committed to growing its asset base in TAG Minerals moving forward.
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
BIOLASE Inc. (BIOL) Given New Patent for Treating Broad Range of Eye Conditions
BIOLASE develops, manufactures, and markets innovative lasers in dentistry and medicine and also markets and distributes high-end 2D and 3D digital imaging equipment and CAD/CAM intraoral scanners. The company’s principal products are revolutionary dental laser systems, making it the world’s leading manufacturer and distributor of dental lasers.
The company announced today that the U.S. Patent and Trademark Office issued it a new patent covering the use of its laser technologies for treating various conditions of the eye, including cataracts, glaucoma, and presbyopia. The patent significantly broadens the claims for the patent family and anticipates using complimentary technologies to streamline procedures to identify the rigidity of the eye to optimize treatment locations in presbyopia procedures, for example.
The latest patent grant is the tenth U.S. patent issued under the “Methods for Treating Eye Conditions” patent family. Three other patents have been issued internationally and six more are pending worldwide. BIOLASE now holds a total of 20 issued and 20 pending U.S. and international patents in seven patent families in the field of ophthalmology. The patents give the company and its OCCULASE subsidiary a wide range of potential applications and coverage in the field.
This new patent is important for the company and its innovative WaterLase technology. Marcia Van Valen, director of business development for BIOLASE, said the patent further leverages the firm’s technology and broadens the patent family “to allow the laser parameters and groupings of tissue treatment to compensate for correlation in the various layers in ocular tissue for treating eye conditions such as presbyopia, cataract and glaucoma.”
For additional information about BIOLASE and its laser technologies, please visit www.biolase.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
The company announced today that the U.S. Patent and Trademark Office issued it a new patent covering the use of its laser technologies for treating various conditions of the eye, including cataracts, glaucoma, and presbyopia. The patent significantly broadens the claims for the patent family and anticipates using complimentary technologies to streamline procedures to identify the rigidity of the eye to optimize treatment locations in presbyopia procedures, for example.
The latest patent grant is the tenth U.S. patent issued under the “Methods for Treating Eye Conditions” patent family. Three other patents have been issued internationally and six more are pending worldwide. BIOLASE now holds a total of 20 issued and 20 pending U.S. and international patents in seven patent families in the field of ophthalmology. The patents give the company and its OCCULASE subsidiary a wide range of potential applications and coverage in the field.
This new patent is important for the company and its innovative WaterLase technology. Marcia Van Valen, director of business development for BIOLASE, said the patent further leverages the firm’s technology and broadens the patent family “to allow the laser parameters and groupings of tissue treatment to compensate for correlation in the various layers in ocular tissue for treating eye conditions such as presbyopia, cataract and glaucoma.”
For additional information about BIOLASE and its laser technologies, please visit www.biolase.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
VizConnect Inc. (VIZC) Offering Small to Medium Businesses a Powerful QR Code-Driven Mobile Marketing Platform
VizConnect is fusing together the power of QR (quick response) code smartphone technology and digital video to bring markets a video marketing platform that is cloud-powered, allowing even small business to easily manage and update an entire print ad campaign’s digital footprint with highly engaging video or other content for the consumer that incentivizes them to act immediately.
Focused on marketing subscriptions to customers ranging up to mid-sized businesses, VIZC is extremely confident that their easy to use, easily accessible, on-line marketing platform nails the mobile/cloud/video formula perfectly. The key here is the marriage of all the right constituent elements into a single distributed platform, combining cloud computing capabilities with the storage and access metrics required to make video marketing not just easy but simple to update in a timely fashion.
Using an intuitive and easy to navigate interface, users can deploy highly relevant and near real-time videos or other content, which can be rapidly associated with a given QR code or a post within the evolving landscape of social media. The VizConnect Mobile Marketing Platform is a one-stop-shop for any size company to quickly vault the hurdles associated with traditional media and touch base with customers right where they live via the mobile device.
This platform even offers branded QR codes (much more visually appealing and prone to get customer’s attention) as a specialized option and makes it a snap to prompt consumers for RSVP/sign-up by automatically directing them to a customizable Call-to-Action page after a video plays where they can respond or further engage the business. Because the VizConnect program is a virtual app and the final edited videos are stored in a single environment, it’s easy to serve them again and again on different campaigns or manage/deploy them effectively. This is an incredible business-to-business service offering that lets companies really connect with target markets in a highly localized fashion, no matter what the print campaign methodology look like.
You can slap a QR code on anything from a mailer, to signage, to a t-shirt, and the digital landscape metrics should be obvious straight away, with linkages that serve whatever site, video or other content the business desires directly to users. The push of a button on the mobile now scans and launches whatever interactive content or video desired via the QR code and you can offer customers a product experience that is on par with what multinationals are doing, all without breaking the bank to do so.
The company runs an attractive compensation plan for IBAs that rewards subscription sales and is helping to drive the model forward, with many subscribers becoming zealots, morphing into distributors that build their own subscriber networks. By actively encouraging proliferation in this manner, VIZC is really putting their product on the map as a unique offering while the cloud/mobile space continues to go supernova. Fully leveraging IBAs (independent business associates) while continually vetting new IBAs into the fold, the company is building a highly-efficient, yet low cost resource that is not only driving bottom line subscription numbers, but making the product-space itself a better deal for new customers.
For more info on VizConnect, visit www.VizConnect.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Focused on marketing subscriptions to customers ranging up to mid-sized businesses, VIZC is extremely confident that their easy to use, easily accessible, on-line marketing platform nails the mobile/cloud/video formula perfectly. The key here is the marriage of all the right constituent elements into a single distributed platform, combining cloud computing capabilities with the storage and access metrics required to make video marketing not just easy but simple to update in a timely fashion.
Using an intuitive and easy to navigate interface, users can deploy highly relevant and near real-time videos or other content, which can be rapidly associated with a given QR code or a post within the evolving landscape of social media. The VizConnect Mobile Marketing Platform is a one-stop-shop for any size company to quickly vault the hurdles associated with traditional media and touch base with customers right where they live via the mobile device.
This platform even offers branded QR codes (much more visually appealing and prone to get customer’s attention) as a specialized option and makes it a snap to prompt consumers for RSVP/sign-up by automatically directing them to a customizable Call-to-Action page after a video plays where they can respond or further engage the business. Because the VizConnect program is a virtual app and the final edited videos are stored in a single environment, it’s easy to serve them again and again on different campaigns or manage/deploy them effectively. This is an incredible business-to-business service offering that lets companies really connect with target markets in a highly localized fashion, no matter what the print campaign methodology look like.
You can slap a QR code on anything from a mailer, to signage, to a t-shirt, and the digital landscape metrics should be obvious straight away, with linkages that serve whatever site, video or other content the business desires directly to users. The push of a button on the mobile now scans and launches whatever interactive content or video desired via the QR code and you can offer customers a product experience that is on par with what multinationals are doing, all without breaking the bank to do so.
The company runs an attractive compensation plan for IBAs that rewards subscription sales and is helping to drive the model forward, with many subscribers becoming zealots, morphing into distributors that build their own subscriber networks. By actively encouraging proliferation in this manner, VIZC is really putting their product on the map as a unique offering while the cloud/mobile space continues to go supernova. Fully leveraging IBAs (independent business associates) while continually vetting new IBAs into the fold, the company is building a highly-efficient, yet low cost resource that is not only driving bottom line subscription numbers, but making the product-space itself a better deal for new customers.
For more info on VizConnect, visit www.VizConnect.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
VIASPACE, Inc. (VSPC) and Our House of Cards
Technology, and the worldwide industrialization it has made possible, has always been viewed with as much suspicion as enthusiasm. By manipulating the world to fit our immediate preferences, the worry is that we may simultaneously be undermining our long-term needs. Our natural and healthy desire for sweet tasting high-calorie foods has led to a sugar and fat-packed world, with 25 million diabetics and 600,000 annual deaths from heart disease in the U.S. alone. Our ability to power machines to do our work, while we remain motionless in front of televisions, computers, and smart phones, has led to an epidemic of obesity never before experienced.
The latest, and arguably the most serious concern, is the fear of uncontrolled climate change brought on by greenhouse gas emissions from the burning of fossil fuels, estimated to be at over 25 billion metric tons of carbon dioxide annually. Although the number of variables affecting global weather patterns is immense, making it impossible for scientists to determine exactly what the effects of global warming will be, or how soon such effects could appear, there’s little disagreement that the climate is changing. Nor is there much disagreement that climate change, whatever form it eventually takes, will be stressful on the human condition, since humanity has geared virtually everything it does to a stable and narrow climate. Our entire agricultural system, for example, has been genetically and chemically fine-tuned, and even small long-term variations can cause a major collapse, an increasingly fragile cornerstone of what is considered by many to be a worldwide technological house of cards.
VIASPACE is one of the few agriculturally oriented companies in the world that can expect its star to rise as concerns about global warming grow. The company’s new proprietary energy crop, called Giant King Grass (GKG), is proving to be one of the most cost effective renewable energy sources on the planet, a dedicated and carbon neutral source of power that absorbs as much carbon dioxide as is released during combustion for energy. It’s more economically viable than other renewable sources because it grows extremely fast and requires no expensive new technologies or infrastructure to implement. In addition, it can generate energy whenever needed, day or night in any type of weather. In fact the company is already signing agreements in various parts of the world with governments anxious for a reliable source of cheap and responsible power.
For additional information, visit www.Viaspace.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
The latest, and arguably the most serious concern, is the fear of uncontrolled climate change brought on by greenhouse gas emissions from the burning of fossil fuels, estimated to be at over 25 billion metric tons of carbon dioxide annually. Although the number of variables affecting global weather patterns is immense, making it impossible for scientists to determine exactly what the effects of global warming will be, or how soon such effects could appear, there’s little disagreement that the climate is changing. Nor is there much disagreement that climate change, whatever form it eventually takes, will be stressful on the human condition, since humanity has geared virtually everything it does to a stable and narrow climate. Our entire agricultural system, for example, has been genetically and chemically fine-tuned, and even small long-term variations can cause a major collapse, an increasingly fragile cornerstone of what is considered by many to be a worldwide technological house of cards.
VIASPACE is one of the few agriculturally oriented companies in the world that can expect its star to rise as concerns about global warming grow. The company’s new proprietary energy crop, called Giant King Grass (GKG), is proving to be one of the most cost effective renewable energy sources on the planet, a dedicated and carbon neutral source of power that absorbs as much carbon dioxide as is released during combustion for energy. It’s more economically viable than other renewable sources because it grows extremely fast and requires no expensive new technologies or infrastructure to implement. In addition, it can generate energy whenever needed, day or night in any type of weather. In fact the company is already signing agreements in various parts of the world with governments anxious for a reliable source of cheap and responsible power.
For additional information, visit www.Viaspace.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
EuroSite Power, Inc. (EUSP) Signs New Installation Agreement with Roko Health Club in York UK
EuroSite Power, provider of On-Site Utility systems and a subsidiary of American DG Energy, Inc., offers clean electricity, heat, hot water, and cooling solutions to hospitality, healthcare, housing, and leisure centers in the United Kingdom (UK) and Europe. The company has signed a new contract to deploy its combined heat and power (CHP) system to the Roko Health Club site in the medieval city of York, UK, and reports that it is also now operating its CHP system supplying clean energy to the Roko Health Club in Nottingham, UK.
The new installation will supply electricity to the club together with heat and hot water to serve both the club and its indoor and outdoor swimming pools. The new agreement marks the fifth system under contract, in addition to system installation at sites in Chiswick, Gillingham, Nottingham, and Portsmouth. The contract carries total revenue value of approximately 1.37 million GBP over the term of the 15-year agreement.
By choosing EuroSite Power’s On-Site Utility solution, Roko will pay only for the energy used and will not incur any capital, installation, and operating costs. Because EuroSite Power is responsible for service, maintenance, and repair, Roko will not need to provide manpower to support the energy equipment.
“We are delighted to have our third system operating. Both our sites in Gillingham and Portsmouth have already begun enjoying savings and we now look forward to seeing similar results at Nottingham. By adding York we have now ensured all our clubs will see a material reduction in both annual energy bills and CO2 emission and all without the need for any capital outlay for Roko Health Clubs,” Neil Stanton, Roko Health Clubs’ operations director, stated in the press release.
The York installation will produce 558,450 kWh of electricity, or approximately 1.3 GWh of total energy per annum, and will reduce CO2 by 123 tonnes each year.
“Leisure centers and health clubs remain an important part of our growth strategy, within the UK market. We strive hard to deliver high quality solutions that deliver good results and the fact that Roko have decided to add another site to their contract speaks volumes,” said Paul Hamblyn, managing director of EuroSite Power.
For more information, visit www.eurositepower.co.uk
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
The new installation will supply electricity to the club together with heat and hot water to serve both the club and its indoor and outdoor swimming pools. The new agreement marks the fifth system under contract, in addition to system installation at sites in Chiswick, Gillingham, Nottingham, and Portsmouth. The contract carries total revenue value of approximately 1.37 million GBP over the term of the 15-year agreement.
By choosing EuroSite Power’s On-Site Utility solution, Roko will pay only for the energy used and will not incur any capital, installation, and operating costs. Because EuroSite Power is responsible for service, maintenance, and repair, Roko will not need to provide manpower to support the energy equipment.
“We are delighted to have our third system operating. Both our sites in Gillingham and Portsmouth have already begun enjoying savings and we now look forward to seeing similar results at Nottingham. By adding York we have now ensured all our clubs will see a material reduction in both annual energy bills and CO2 emission and all without the need for any capital outlay for Roko Health Clubs,” Neil Stanton, Roko Health Clubs’ operations director, stated in the press release.
The York installation will produce 558,450 kWh of electricity, or approximately 1.3 GWh of total energy per annum, and will reduce CO2 by 123 tonnes each year.
“Leisure centers and health clubs remain an important part of our growth strategy, within the UK market. We strive hard to deliver high quality solutions that deliver good results and the fact that Roko have decided to add another site to their contract speaks volumes,” said Paul Hamblyn, managing director of EuroSite Power.
For more information, visit www.eurositepower.co.uk
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Mabwe Minerals Inc. (MBMI) Engages QualityStocks Investor Relations Services
Mabwe Minerals Inc. announced earlier today that they have agreed with QualityStocks to be featured in The Small Cap QualityStocks Daily Newsletter, QualityStocks Daily Blogs and Message Boards. QualityStocks, based in Scottsdale, Arizona, is a free service that collates data from hundreds of Small-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts.
Along with its affiliate, Mabwe Minerals Zimbabwe (Private) Ltd., the company owns 100% of the mineral & metal rights to Dodge Mine. The mine will be managed by Mabwe Minerals’ minority owned partner, WGB Kinsey & Company, Zimbabwe’s most experienced mining & construction company representing four generations of Kinsey leadership. Management believes WGB Kinsey & Company has all the necessary equipment and management experience to efficiently perform all the mining operations at Dodge Mine.
The Dodge Mine property consists of three hydrothermal mountains representing 123 hectares containing multiple deposits of superior-grade barite, limestone, and talc. Hydrothermal barite deposits throughout Dodge Mine represent the highest grade of new barite sources to be brought into commercial production in years. A third party oil & gas drilling sector geologist recently confirmed that the multiple barite deposits are considered “World Class” in quality and highly efficient to mine via open pit extraction following the barite veins and salvaging large percentages of barite within the halo zones via jigging systems.
Al Pietrangelo, CEO of Mabwe Minerals, stated, “Transitioning into commercial production with virtually no debt, MBMI is well positioned to generate significant shareholder returns. We appreciate the opportunity to sponsor the QualityStocks Newsletter, Videos and Blogs. QualityStocks is providing a much needed service in the micro-cap and small-cap markets.”
For more information, visit www.RaptorResourcesHoldings.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Along with its affiliate, Mabwe Minerals Zimbabwe (Private) Ltd., the company owns 100% of the mineral & metal rights to Dodge Mine. The mine will be managed by Mabwe Minerals’ minority owned partner, WGB Kinsey & Company, Zimbabwe’s most experienced mining & construction company representing four generations of Kinsey leadership. Management believes WGB Kinsey & Company has all the necessary equipment and management experience to efficiently perform all the mining operations at Dodge Mine.
The Dodge Mine property consists of three hydrothermal mountains representing 123 hectares containing multiple deposits of superior-grade barite, limestone, and talc. Hydrothermal barite deposits throughout Dodge Mine represent the highest grade of new barite sources to be brought into commercial production in years. A third party oil & gas drilling sector geologist recently confirmed that the multiple barite deposits are considered “World Class” in quality and highly efficient to mine via open pit extraction following the barite veins and salvaging large percentages of barite within the halo zones via jigging systems.
Al Pietrangelo, CEO of Mabwe Minerals, stated, “Transitioning into commercial production with virtually no debt, MBMI is well positioned to generate significant shareholder returns. We appreciate the opportunity to sponsor the QualityStocks Newsletter, Videos and Blogs. QualityStocks is providing a much needed service in the micro-cap and small-cap markets.”
For more information, visit www.RaptorResourcesHoldings.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
The Guitammer Company Inc. (GTMM) Goes Supersonic at Brooklands Museum
The Guitammer Company, a leader in low frequency sound and creator of the award-winning line of ButtKicker®-brand low frequency audio transducers that provide an immersive entertainment experience, today announced the installation of its ButtKicker Advance tactile transducers into the original passenger seating at the Concorde Experience at Brooklands Museum, the birthplace of British motorsport and aviation, to create a realistic and unique dimension to each visitor’s virtual flight.
Gordon Roxburgh, head of the Concorde Experience team at Brooklands, commented, “We wanted to emulate the physical sensations normally experienced within the aircraft for the duration of the flight so that our visitors had an added sense of realism. The ButtKicker Advance units translate this feeling perfectly and bring the whole flight experience to life.”
The Brooklands Museum’s Concorde Experience allows visitors to have a first-hand opportunity to experience over a half an hour of virtual flight travel complete with visual, physical, and audio stimulation. Now that Guitammer’s transducers are also installed in the British Airways Concorde simulator, the flight experience offers a realistic, tactile effect to the pilot seats in the full-size static simulator.
The iconic Concorde aircraft has been a feature at Brooklands since it was officially opened by HRH Prince Michael of Kent in 2006 after a two-year restoration project. More information about the Concorde experience can be found at www.brooklandsmuseum.com.
To learn more about Guitammer, visit www.guitammer.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Gordon Roxburgh, head of the Concorde Experience team at Brooklands, commented, “We wanted to emulate the physical sensations normally experienced within the aircraft for the duration of the flight so that our visitors had an added sense of realism. The ButtKicker Advance units translate this feeling perfectly and bring the whole flight experience to life.”
The Brooklands Museum’s Concorde Experience allows visitors to have a first-hand opportunity to experience over a half an hour of virtual flight travel complete with visual, physical, and audio stimulation. Now that Guitammer’s transducers are also installed in the British Airways Concorde simulator, the flight experience offers a realistic, tactile effect to the pilot seats in the full-size static simulator.
The iconic Concorde aircraft has been a feature at Brooklands since it was officially opened by HRH Prince Michael of Kent in 2006 after a two-year restoration project. More information about the Concorde experience can be found at www.brooklandsmuseum.com.
To learn more about Guitammer, visit www.guitammer.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Real Goods, Inc. (RSOL) Solar Selected to Aid in Expansion of Solar Adoption in Select Massachusetts Communities
Real Goods Solar, a nationwide leader of turnkey solar energy solutions for residential, commercial, and utility customers, yesterday announced that it has been selected as a 2013 Solarize Mass Installer by the Massachusetts Clean Energy Center (MassCEC) and the Green Communities Division of the MA Department of Energy Resources (DOER) to bring solar electricity to home and business owners in Massachusetts through the Solarize Mass program.
Real Goods Solar, in partnership with MassCEC, will work with Solarize Mass Community Solar Coaches to implement the Solarize Mass program in the Massachusetts communities of Northampton, Lee, and Williamstown.
The goal of the Solarize programs is to increase the adoption of solar energy and further reduce the overall cost of solar power. Additionally, the program offers residents and businesses discounted pricing for solar through tiered community-based incentives. Greater savings can be enjoyed as more members of a particular community participate.
“We’ve realized great success with previous Solarize programs, and we expect this one to be even stronger,” commented Real Goods Solar CEO Kam Mofid. “Through the 2011 Solarize Mass Pilot program, Real Goods Solar helped Hatfield and Winchester Massachusetts collectively achieve more than 200 kilowatts of solar power capacity. We were also able to more than double the amount of solar in Portland, Connecticut by installing more than 342 kilowatts through the Solarize Connecticut pilot program.”
Beginning April 2013, as part of the effort to reach Governor Patrick’s goal of 250 megawatts of solar power installed by 2017, Massachusetts Energy and Environmental Affairs Secretary Richard K. Sullivan Jr. announced that MassCEC and the Department of Energy Resources had selected the cities and towns of Bourne, Brookline, Carlisle, Chelmsford, Lee, Medford, Medway, Newton, Northampton, and Williamstown to participate in the first round of the 2013 Solarize Mass program. The state is close to reaching its goal – 243 megawatts of solar electricity installed to date or the equivalent of powering 38,000 homes for a year as a result of the Solarize mass program and other incentives.
MassCEC CEO Alicia Barton, said, “This program brings together residents, local and state officials, and solar industry workers to form a truly grassroots effort. With everyone at the table, we can spread the word about the economic and environmental benefits of solar power across 10 communities.”
The Solarize Mass programs in Lee, Williamstown and Northampton are planned to continue through summer. Home and business owners will have until September 30, 2013 to register for their savings.
For more information on Real Goods Solar, please visit www.RealGoodsSolar.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Real Goods Solar, in partnership with MassCEC, will work with Solarize Mass Community Solar Coaches to implement the Solarize Mass program in the Massachusetts communities of Northampton, Lee, and Williamstown.
The goal of the Solarize programs is to increase the adoption of solar energy and further reduce the overall cost of solar power. Additionally, the program offers residents and businesses discounted pricing for solar through tiered community-based incentives. Greater savings can be enjoyed as more members of a particular community participate.
“We’ve realized great success with previous Solarize programs, and we expect this one to be even stronger,” commented Real Goods Solar CEO Kam Mofid. “Through the 2011 Solarize Mass Pilot program, Real Goods Solar helped Hatfield and Winchester Massachusetts collectively achieve more than 200 kilowatts of solar power capacity. We were also able to more than double the amount of solar in Portland, Connecticut by installing more than 342 kilowatts through the Solarize Connecticut pilot program.”
Beginning April 2013, as part of the effort to reach Governor Patrick’s goal of 250 megawatts of solar power installed by 2017, Massachusetts Energy and Environmental Affairs Secretary Richard K. Sullivan Jr. announced that MassCEC and the Department of Energy Resources had selected the cities and towns of Bourne, Brookline, Carlisle, Chelmsford, Lee, Medford, Medway, Newton, Northampton, and Williamstown to participate in the first round of the 2013 Solarize Mass program. The state is close to reaching its goal – 243 megawatts of solar electricity installed to date or the equivalent of powering 38,000 homes for a year as a result of the Solarize mass program and other incentives.
MassCEC CEO Alicia Barton, said, “This program brings together residents, local and state officials, and solar industry workers to form a truly grassroots effort. With everyone at the table, we can spread the word about the economic and environmental benefits of solar power across 10 communities.”
The Solarize Mass programs in Lee, Williamstown and Northampton are planned to continue through summer. Home and business owners will have until September 30, 2013 to register for their savings.
For more information on Real Goods Solar, please visit www.RealGoodsSolar.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Posts (Atom)
